No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
8744 |
4. Check minimum number of eventsNone |
8744 |
5. Include endpointsNone |
8744 |
6. Filter based on genotype QC (FinnGen only) |
8744 |
Control definitions (FinnGen only)
- Control exclude
- J10_UPPERDIS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- J30-J39
- Name in latin
- Polypus nasi
Similar endpoints
↥List of similar endpoints to
Nasal polyp
based on the number of shared cases.
Similar with more cases:
- Other diseases of upper respiratory tract
- Diseases of the respiratory system
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 59117 | 20506 | 38226 |
| Only index persons | 53927 | 19156 | 34771 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.90 | 0.59 | 1.07 |
| Only index persons | 1.11 | 0.70 | 1.33 |
| Median age at first event (years) | |||
| Whole population | 50.67 | 48.92 | 51.58 |
| Only index persons | 49.79 | 48.11 | 50.71 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 8744 | 3406 | 5338 |
| Unadjusted period prevalence (%) | 1.89 | 1.16 | 2.35 |
| Median age at first event (years) | 50.87 | 46.69 | 53.53 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 7799
- Matched controls
- 77989
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R03DC03
ATC
montelukast; oral
7.4
323.0
2454
4562
J33.0
ICD-10 Finland
Polyp of nasal cavity
2030.1
323.0
4626
55
J45.9
ICD-10 Finland
Asthma, unspecified
6.1
323.0
2595
5865
J33.8
ICD-10 Finland
Other polyp of sinus
4196.8
323.0
3436
16
R01AD08
ATC
fluticasone; nasal
20.0
323.0
5788
9800
J45.1
ICD-10 Finland
Nonallergic asthma
6.9
323.0
1070
1747
DJD20
NOMESCO Finland
Plastic repair of septum of nose
214.7
323.0
704
36
R03AC02
ATC
salbutamol; inhalant
3.7
323.0
4992
25439
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
4.6
323.0
2390
6798
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.0
323.0
1623
4830
J45
ICD-10 Finland
Asthma
5.9
323.0
1349
2675
R03BA01
ATC
beclometasone; inhalant
3.8
323.0
1576
4838
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
+∞
323.0
458
*
J32.4
ICD-10 Finland
Chronic pansinusitis
1945.6
323.0
985
6
H02AB04
ATC
methylprednisolone; systemic
4.9
323.0
1975
5066
H02AB07
ATC
prednisone; oral
3.9
323.0
1721
5282
R01AD11
ATC
triamcinolone; nasal
5.6
323.0
1179
2383
4711A
ICD-9 Finland
Nasal polyps, Polypoid sinus degeneration
+∞
323.0
549
*
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
+∞
323.0
432
*
R01BA52
ATC
pseudoephedrine, combinations; oral
3.6
323.0
3202
12741
J01FA10
ATC
azithromycin; systemic
2.6
323.0
4748
28930
J33.9
ICD-10 Finland
Nasal polyp, unspecified
194.9
323.0
913
53
R01AD09
ATC
mometasone; nasal
7.8
323.0
5588
19109
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
1665.4
323.0
2081
17
R01AD01
ATC
beclometasone; nasal
6.6
323.0
2406
4925
R03BA02
ATC
budesonide; inhalant
4.0
323.0
1973
6023
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.0
323.0
4610
25634
H02AB06
ATC
prednisolone; systemic
5.9
323.0
5563
23044
DHB50
NOMESCO Finland
Turbinoplasty
236.8
323.0
571
26
J01AA02
ATC
doxycycline; systemic
3.4
323.0
6538
47317
R03AK07
ATC
formoterol and budesonide; inhalant
3.6
323.0
2069
7187
R01AD12
ATC
fluticasone furoate; nasal
4.5
323.0
3315
10967
J45.0
ICD-10 Finland
Predominantly allergic asthma
8.7
323.0
1364
1854
J34.2
ICD-10 Finland
Deviated nasal septum
183.5
323.0
994
62
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
110.4
323.0
2506
333
J01.0
ICD-10 Finland
Acute maxillary sinusitis
4.8
323.0
2464
6891
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
49.3
323.0
644
142
ZXA10
NOMESCO Finland
Bilateral
4.3
323.0
2256
6803
UDM02
NOMESCO Finland
Sinoscopy
86.6
323.0
941
123
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
+∞
323.0
511
*
50503
ICD-8 Finland
Nasal polyp, Ethmoidalis
+∞
323.0
330
*
4222
FHL
Endonasal etmoidectomy
795.3
323.0
521
7
TDM10
NOMESCO Finland
Puncture of maxillary antrum
53.3
323.0
1345
304
R01AD05
ATC
budesonide; nasal
11.6
323.0
1631
1743
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
872.3
323.0
3130
59
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
1142.2
323.0
533
5
J31.0
ICD-10 Finland
Chronic rhinitis
22.5
323.0
1128
581
J34.1
ICD-10 Finland
Cyst and mucocele of nose and nasal sinus
224.8
323.0
344
16
DHB20
NOMESCO Finland
Polypectomy of internal nose
2525.4
323.0
2119
12
R03BA05
ATC
fluticasone; inhalant
3.8
323.0
1982
6374
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
6.5
323.0
3026
6948
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
47.5
323.0
1255
313
DPA30
NOMESCO Finland
Sphenotomy
694.9
323.0
397
6
UDH02
NOMESCO Finland
Rhinopharyngoscopy
35.6
323.0
2222
863
R06AE07
ATC
cetirizine; oral
2.6
320.9
3591
19389
R06AX27
ATC
desloratadine; oral
3.0
317.8
2366
9974
J33
ICD-10 Finland
Nasal polyp
99.6
311.1
343
36
4221
FHL
Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room
270.2
305.4
311
12
R96
ICPC
Asthma
5.0
301.2
1065
2391
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
194.9
288.8
300
16
DHA10
NOMESCO Finland
Biopsy of cavity of nose
58.6
284.2
337
60
4224
FHL
Endonasal anthrostomy
195.6
272.5
283
15
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
4.2
262.6
1102
2917
R03AC03
ATC
terbutaline; inhalant
3.5
261.1
1407
4617
J30.3
ICD-10 Finland
Other allergic rhinitis
16.3
250.8
417
270
J01CA04
ATC
amoxicillin; systemic
2.5
249.7
6303
48647
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.6
242.3
2305
10937
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
282.0
241.0
245
9
J01FA09
ATC
clarithromycin; systemic
2.4
232.6
2655
13822
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
+∞
231.4
221
*
50499
ICD-8 Finland
Deflected nasal septum
+∞
231.4
221
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
6.5
230.1
639
1058
R03AC12
ATC
salmeterol; inhalant
6.4
228.8
645
1089
4226
FHL
Posterior radical surgery and possible etmoidectomy
745.6
222.1
218
*
DPW99
NOMESCO Finland
Other operation on frontal or sphenoidal sinus
+∞
220.8
211
*
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
9.9
209.9
439
465
J35.0
ICD-10 Finland
Chronic tonsillitis
64.2
208.0
243
39
R06AE09
ATC
levocetirizine; oral
3.1
201.9
1290
4715
4700A
ICD-9 Finland
Deflected nasal septum[DEFORMATIO SEPTI NASI]
+∞
196.6
188
*
49300
ICD-8 Finland
Asthma, bronchiale
9.0
191.7
425
498
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
58.1
190.5
226
40
R03BA08
ATC
ciclesonide; inhalant
4.0
187.2
830
2272
XQ800
NOMESCO Finland
Prick test
4.6
185.3
702
1655
50501
ICD-8 Finland
Nasal polyp, Maxillaris
+∞
183.0
175
*
R06AX22
ATC
ebastine; oral
2.7
181.9
1429
5928
R03AC13
ATC
formoterol; inhalant
5.1
179.6
607
1267
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.8
175.7
829
2389
J01FA06
ATC
roxithromycin; oral
2.0
172.4
3144
19514
DMB10
NOMESCO Finland
Radical maxillary antrotomy
577.1
171.9
170
*
J46
ICD-10 Finland
Status asthmaticus
8.2
161.7
378
482
J32.1
ICD-10 Finland
Chronic frontal sinusitis
280.2
161.2
164
6
R06AX13
ATC
loratadine; oral
2.7
159.5
1233
5030
J45.8
ICD-10 Finland
Mixed asthma
7.2
159.1
405
588
R03AK08
ATC
formoterol and beclometasone; inhalant
6.0
152.1
445
780
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
19.3
150.6
234
125
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.4
150.3
416
678
EMB10
NOMESCO Finland
Tonsillectomy
13.4
146.4
262
201
4239
FHL
Other measure in this category
490.1
145.9
145
*
J01FA15
ATC
telithromycin; oral
3.0
144.9
943
3434
4732A
ICD-9 Finland
Chronic sinusitis, Ethmoidal
+∞
143.1
137
*
R03BB04
ATC
tiotropium bromide; inhalant
2.9
142.3
960
3576
R03DA04
ATC
theophylline; systemic, rectal
4.3
140.9
569
1417
J37.0
ICD-10 Finland
Chronic laryngitis
23.0
140.6
206
92
R09
ICPC
Sinus symptom/complaint
3.8
140.4
644
1799
J32.8
ICD-10 Finland
Other chronic sinusitis
123.9
135.5
146
12
DNB10
NOMESCO Finland
Endonasal ethmoidectomy
674.6
135.1
133
*
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
8.1
133.5
313
400
J01DB01
ATC
cefalexin; oral
2.0
133.3
6188
51534
J33.1
ICD-10 Finland
Polypoid sinus degeneration
+∞
132.6
127
*
J01DA06
ATC
[U] cefuroxime; systemic
2.5
130.9
1226
5514
ZXD20
NOMESCO Finland
Day surgery
2.5
126.3
1095
4718
J30.0
ICD-10 Finland
Vasomotor rhinitis
11.4
125.1
242
219
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
622.8
124.6
123
*
4719X
ICD-9 Finland
Nasal polyps, Unspecified nasal polyp
+∞
124.3
119
*
ZXC60
NOMESCO Finland
Application of heat
14.2
123.4
215
155
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
4.7
121.5
435
958
H65.3
ICD-10 Finland
Chronic mucoid otitis media
10.5
120.2
242
237
DHB40
NOMESCO Finland
Conchotomy
591.8
118.4
117
*
4211
FHL
Transeptal septal resection and reconstruction
129.0
118.4
127
10
J01.1
ICD-10 Finland
Acute frontal sinusitis
10.7
115.2
229
219
R06AX26
ATC
fexofenadine; oral
3.6
113.1
558
1647
50304
ICD-8 Finland
Chronic sinusitis, Ethmoidalis
+∞
112.7
108
*
4779A
ICD-9 Finland
Allergic rhinitis, Cause unspecified
+∞
110.7
106
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
109.9
2848
19122
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.2
109.6
442
1094
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.2
108.2
1333
6785
J01DA01
ATC
[U] cefalexin; systemic
1.7
106.7
4562
35423
50300
ICD-8 Finland
Chronic sinusitis, Maxillaris cum empyemate
+∞
106.5
102
*
A02BC02
ATC
pantoprazole; systemic
1.7
106.1
4689
36727
R03AK11
ATC
formoterol and fluticasone; inhalant
6.2
106.1
299
497
ZXC95
NOMESCO Finland
Use of surgical navigator
9.6
105.3
222
237
J01DC02
ATC
cefuroxime; systemic
3.5
104.0
521
1554
XG474
NOMESCO Finland
Exhalation nntrogen oxide
6.4
103.5
284
456
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
5.0
103.2
348
717
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
41.0
102.3
129
32
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
10.9
101.3
199
186
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
98.6
2767
18859
R03DC01
ATC
zafirlukast; oral
8.1
95.5
223
283
4452
FHL
Tonsil surgery
34.3
95.4
125
37
50509
ICD-8 Finland
Nasal polyp, Unspecified
+∞
95.0
91
*
J36
ICD-10 Finland
Peritonsillar abscess
28.1
94.4
130
47
J01
ICD-10 Finland
Acute sinusitis
4.0
94.2
404
1056
4740A
ICD-9 Finland
Chronic disease of tonsils and adenoids, Chronic tonsillitis
+∞
93.9
90
*
UDC00
NOMESCO Finland
Ear microscopy
2.9
93.3
621
2266
J01.4
ICD-10 Finland
Acute pansinusitis
16.7
92.8
151
92
N02BE01
ATC
paracetamol; systemic, rectal
1.8
90.3
6314
54953
R75
ICPC
Sinusitis acute/chronic
4.1
89.5
375
959
ZXE00
NOMESCO Finland
One hour or less
1.7
87.2
2820
19829
50709
ICD-8 Finland
Hay fever, Unspecified
+∞
86.6
83
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
86.0
2008
12817
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
4.7
85.4
308
681
R07
ICPC
Sneezing/nasal congestion
3.2
85.0
477
1547
WX002
NOMESCO Finland
Sedation and analgesia
1.9
84.9
1476
8528
A02BC05
ATC
esomeprazole; systemic
1.7
84.8
2790
19666
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
81.0
2618
18305
R01BA51
ATC
phenylpropanolamine, combinations; oral
2.3
80.9
792
3585
DPA20
NOMESCO Finland
Trephine of frontal sinus
124.2
80.0
86
7
H65.2
ICD-10 Finland
Chronic serous otitis media
9.9
79.9
165
170
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.0
79.2
490
1700
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
7.8
78.7
187
244
R08
ICPC
Nose symptom/complaint other
4.5
78.4
291
663
R01AD
ATC
Corticosteroids
9.5
76.7
162
174
R06.5
ICD-10 Finland
Mouth breathing
2.5
75.8
667
2852
J32
ICD-10 Finland
Chronic sinusitis
27.0
74.9
104
39
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
12.3
74.7
138
114
R06.0
ICD-10 Finland
Dyspnoea
1.8
74.2
1653
10319
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
73.9
3254
24455
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
23.9
73.7
106
45
R02
ICPC
Shortness of breath/dyspnoea
2.2
72.9
849
4156
G47.3
ICD-10 Finland
Sleep apnoea
1.8
71.2
1593
9937
DHB10
NOMESCO Finland
Excision of lesion of internal nose
23.5
70.6
102
44
J01DA08
ATC
[U] cefaclor; oral
2.3
70.1
690
3120
4451
FHL
Guitar cutting
15.1
70.0
118
79
50708
ICD-8 Finland
Hay fever, Alia definita
+∞
69.9
67
*
J01MA14
ATC
moxifloxacin; systemic
2.3
69.0
704
3240
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
68.5
3070
23036
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
7.6
65.6
158
211
Z51.6
ICD-10 Finland
Desensitization to allergens
27.6
65.3
90
33
WX110
NOMESCO Finland
Local anesthesy
1.5
63.5
4814
40337
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
114.3
62.9
68
6
XG410
NOMESCO Finland
Flow-volume spirometry
3.2
62.8
345
1099
Z2221
NOMESCO Finland
Medical doctor
1.6
62.2
1895
12839
4212
FHL
Maxillapremmaxilla opening septum resection and reconstruction
71.5
62.2
71
10
J02AC01
ATC
fluconazole; systemic
1.6
62.1
2280
16202
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.9
61.1
408
1480
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
60.7
1439
9080
R05
ICD-10 Finland
Cough
1.8
60.4
1217
7297
C01CA24
ATC
epinephrine; parenteral
2.8
60.1
402
1461
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
13.1
59.8
107
83
J01MA02
ATC
ciprofloxacin; systemic
1.5
58.6
2712
20279
R01AC01
ATC
cromoglicic acid; nasal
3.7
58.5
270
751
J32.3
ICD-10 Finland
Chronic sphenoidal sinusitis
+∞
58.4
56
*
S01GX01
ATC
cromoglicic acid; ophthalmic
1.8
58.2
1131
6697
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
57.9
2524
18610
4742A
ICD-9 Finland
Chronic disease of tonsils and adenoids, Adenoid vegetations
+∞
57.3
55
*
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
5.6
57.1
173
316
R01BA01
ATC
phenylpropanolamine; oral
2.7
54.9
409
1588
J35.1
ICD-10 Finland
Hypertrophy of tonsils
100.8
54.8
60
6
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
52.4
1468
9662
4710A
ICD-9 Finland
Nasal polyps, Polyp of nasal cavity
+∞
52.1
50
*
A02BC03
ATC
lansoprazole; oral
1.6
51.7
1895
13344
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.7
51.6
380
1464
R06.2
ICD-10 Finland
Wheezing
3.0
51.5
316
1087
DPB00
NOMESCO Finland
Partial excision of frontal sinus
511.2
51.5
51
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.9
51.3
895
5092
R74
ICPC
Upper respiratory infection acute
1.6
50.8
1614
10966
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.6
50.3
1650
11299
J01FF01
ATC
clindamycin; systemic
1.6
49.5
1810
12714
4225
FHL
Exploratory buccal opening, includes polyps and cyst removal
63.7
49.2
57
9
J47
ICD-10 Finland
Bronchiectasis
5.1
49.1
161
323
A07AA02
ATC
nystatin; oral
2.5
48.7
405
1672
N02AX02
ATC
tramadol; systemic, rectal
1.4
48.5
2855
22205
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
6.9
48.2
123
180
SPAT1058
SPAT
PEF monitoring instruction
2.2
48.2
551
2658
J35.2
ICD-10 Finland
Hypertrophy of adenoids
+∞
47.9
46
*
D07AC01
ATC
betamethasone; topical
1.5
47.1
2272
16942
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
76.3
47.0
53
7
4718X
ICD-9 Finland
Nasal polyps, Other polyp of sinus
+∞
46.9
45
*
J20
ICD-10 Finland
Acute bronchitis
2.0
46.6
606
3085
DM1CI
NOMESCO Finland
Very extensive cone beam CT of paranasal sinus
65.3
45.1
52
8
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
45.0
1297
8559
50199
ICD-8 Finland
Peritonsillar abscess
+∞
44.8
43
*
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
44.5
1751
12459
297
Kela drug reimbursment
NA
440.1
44.2
44
*
3028
Kela drug reimbursment
Mepolizumab
440.1
44.2
44
*
A01AB09
ATC
miconazole; local oral
2.1
44.1
524
2566
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
43.6
1828
13181
R01AC02
ATC
levocabastine; nasal
3.5
43.4
209
603
R05
ICPC
Cough
1.6
42.9
1341
9021
4781C
ICD-9 Finland
Other diseases of upper respiratory tract, Other diseases of nasal cavity and sinuses[CYSTA SINUS MAXILLARIS]
+∞
42.7
41
*
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
11.5
42.5
80
70
R03BC03
ATC
nedocromil; inhalant
2.2
42.2
444
2057
1210
FHL
Anthroscopy
20.5
42.1
63
31
D72.1
ICD-10 Finland
Eosinophilia
11.7
41.8
78
67
J01MA12
ATC
levofloxacin; systemic
1.6
41.8
1250
8313
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
+∞
41.7
40
*
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
3.7
41.6
191
530
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
41.4
1557
10941
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
40.9
2429
18756
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
40.6
2106
15832
R03DX09
ATC
mepolizumab; parenteral
399.5
40.1
40
*
R01AX03
ATC
ipratropium bromide; nasal
3.9
40.0
171
447
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
39.9
4678
40613
4741B
ICD-9 Finland
Chronic disease of tonsils and adenoids, Hypertrophy of tonsils and adenoids[HYPERTROPHIA TONSILLAE PHARYNGICAE]
+∞
39.6
38
*
D07AC13
ATC
mometasone; topical
1.5
39.0
1894
14032
4738X
ICD-9 Finland
Chronic sinusitis, Other chronic sinusitis
+∞
38.6
37
*
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
38.3
3111
25322
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
38.1
2365
18350
DMA10
NOMESCO Finland
Exploration of maxillary antrum
72.2
37.9
43
6
E0000UV
ATC
NA
1.4
37.8
2398
18679
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
37.3
740
4369
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
36.8
1730
12703
H66.9
ICD-10 Finland
Otitis media, unspecified
2.5
36.8
306
1263
DFF00
NOMESCO Finland
Pure tone audiometry
1.9
36.5
588
3238
A02BC01
ATC
omeprazole; systemic
1.5
36.4
1703
12488
R06AX12
ATC
terfenadine; oral
2.5
36.1
300
1239
M03BX02
ATC
tizanidine; oral
1.4
36.1
4074
34866
J30
ICD-10 Finland
Vasomotor and allergic rhinitis
5.1
35.9
116
230
ZXC99
NOMESCO Finland
Other special technic in surgery
31.5
35.6
47
15
ZXA00
NOMESCO Finland
Right side
1.5
35.3
1721
12715
J31.1
ICD-10 Finland
Chronic nasopharyngitis
13.6
35.1
61
45
J38.3
ICD-10 Finland
Other diseases of vocal cords
29.5
35.1
47
16
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.4
34.8
317
1372
M79.6
ICD-10 Finland
Pain in limb
1.4
34.7
2147
16587
UJF32
NOMESCO Finland
Coloscopy
1.5
34.7
1619
11853
H01
ICPC
Ear pain/earache
1.9
34.5
572
3183
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
3.8
33.9
146
385
Z3231
NOMESCO Finland
Registered nurse
1.4
33.4
1763
13205
4750B
ICD-9 Finland
Peritonsillar abscess[PERITONSILLITIS ABSCEDENS]
+∞
33.3
32
*
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.9
32.9
548
3051
R06AX18
ATC
acrivastine; oral
3.0
32.6
195
661
R51.80
ICD-10 Finland
Headache
1.7
32.3
770
4791
ZXA05
NOMESCO Finland
Left side
1.4
32.2
1606
11884
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
32.2
1054
7126
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.9
32.2
520
2863
R05FB02
ATC
cough suppressants and expectorants
1.4
31.6
2322
18414
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
6.4
31.5
84
132
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
31.0
1673
12553
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
30.8
3584
30492
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.2
30.8
325
1509
SPAT1059
SPAT
Spirometry at the office
2.1
30.7
346
1652
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
110.4
30.7
33
*
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.6
30.6
234
923
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
12.0
30.6
56
47
EMB30
NOMESCO Finland
Adenotomy
13.3
30.3
53
40
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
30.3
755
4752
Z71.8
ICD-10 Finland
Other specified counselling
1.5
30.2
1380
10020
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.0
30.0
424
2225
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
29.9
2027
15828
R03BB01
ATC
ipratropium bromide; inhalant
2.5
29.8
243
993
B97.7
ICD-10 Finland
Papillomavirus as the cause of diseases classified to other chapters
11.3
29.7
56
50
SPAT1036
SPAT
Maxillary puncture
18.8
29.5
45
24
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
29.3
2511
20359
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
8.5
29.1
64
76
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
28.8
1359
9919
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
11.8
28.8
53
45
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
28.7
4656
41354
H65.0
ICD-10 Finland
Acute serous otitis media
4.4
28.6
106
244
R01AC07
ATC
nedocromil; nasal
10.1
28.5
57
57
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.5
28.4
1013
6972
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
27.9
1686
12879
G50.1
ICD-10 Finland
Atypical facial pain
4.0
27.9
115
293
R21
ICPC
Throat symptom/complaint
1.5
27.8
970
6638
P01AB01
ATC
metronidazole; oral, rectal
1.3
27.8
2317
18662
R03BC01
ATC
cromoglicic acid; inhalant
4.1
27.6
108
263
4453
FHL
Other and tonsil surgery
35.1
27.4
35
10
T78.4
ICD-10 Finland
Allergy, unspecified
2.4
27.2
245
1055
M25.5
ICD-10 Finland
Pain in joint
1.4
27.2
1621
12342
4720A
ICD-9 Finland
Chronic pharyngitis and nasopharyngitis, Chronic rhinitis[RHINITIS CHRONICA HYPERTROPHICA]
+∞
27.1
26
*
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
6.0
27.1
75
125
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.6
27.1
207
819
4618A
ICD-9 Finland
Acute sinusitis, Other acute sinusitis
14.0
27.0
46
33
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
26.9
1401
10404
WX290
NOMESCO Finland
Other blockade of nerve
1.3
26.8
2702
22360
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
75.4
26.8
30
*
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
5.5
26.7
80
147
A01AB04
ATC
amphotericin B; local oral
2.2
26.5
265
1203
EMB20
NOMESCO Finland
Adenotonsillectomy
34.1
26.4
34
10
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
26.0
2737
22761
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
26.0
2300
18653
4252
FHL
Resection, coagulation or cryo on the cortex and nasal mucosa
60.2
25.9
30
5
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
25.7
3668
31787
4227
FHL
Forehead cavity drainage
18.7
25.6
39
21
L20.0
ICD-10 Finland
Besnier prurigo
2.0
25.3
316
1577
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
5.1
25.3
81
161
R07.0
ICD-10 Finland
Pain in throat
2.1
25.3
304
1495
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
25.2
589
3640
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
25.2
674
4318
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
25.2
1009
7107
SPAT1263
SPAT
Sampling
1.3
25.1
2605
21596
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
25.1
1053
7490
SPAT1325
SPAT
Vaccination
1.3
25.0
2057
16473
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.9
24.7
374
2013
M54.5
ICD-10 Finland
Low back pain
1.3
24.7
1904
15098
XG405
NOMESCO Finland
Education on PEF monitoring
3.8
24.6
106
282
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.5
24.5
847
5771
J02AC02
ATC
itraconazole; systemic
1.5
24.5
1038
7391
R13
ICD-10 Finland
Dysphagia
1.9
24.4
359
1910
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
24.3
1741
13635
R05FA02
ATC
opium derivatives and expectorants; systemic
1.3
24.3
2408
19810
DMW00
NOMESCO Finland
Intubation of maxillary antrum
20.1
24.3
36
18
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
24.2
900
6238
R43.0
ICD-10 Finland
Anosmia
5.2
24.2
75
144
A02BA02
ATC
ranitidine; systemic
1.4
24.1
1148
8364
3027
Kela drug reimbursment
Benralizumab
+∞
24.0
23
*
R01AD04
ATC
flunisolide; nasal
5.5
23.8
71
130
K02.1
ICD-10 Finland
Caries of dentine
1.3
23.6
3592
31248
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
23.5
3312
28528
G04CA02
ATC
tamsulosin; oral
1.4
23.4
1691
13249
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
23.3
871
6039
D07AD01
ATC
clobetasol; topical
1.5
23.1
909
6368
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
24.7
23.0
32
13
WQ000
NOMESCO Finland
Hyposensibilisation
20.1
22.9
34
17
251
Kela drug reimbursment
NA
+∞
22.9
22
*
R03DX10
ATC
benralizumab; systemic
+∞
22.9
22
*
J01FA01
ATC
erythromycin; systemic
1.5
22.9
741
4971
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
7.9
22.8
52
66
A98
ICPC
Health maint/preventive medicine
1.5
22.7
7080
67813
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.8
22.5
428
2488
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
22.5
542
3378
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
8.7
22.0
47
54
R03CC02
ATC
salbutamol; systemic
2.3
21.9
215
967
4939B
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]
15.1
21.9
36
24
R04.0
ICD-10 Finland
Epistaxis
1.8
21.9
424
2476
Z3226
NOMESCO Finland
Physiotherapist
1.4
21.8
1081
7930
E000002
ATC
NA
1.6
21.5
626
4091
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
21.4
1568
12285
GD1AA
SPAT
NA
1.8
21.3
388
2224
N03AX16
ATC
pregabalin; oral
1.4
21.3
1316
10031
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
21.2
2557
21499
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
21.0
3989
35444
R83
ICPC
Respiratory infection other
1.4
21.0
1240
9375
4122
FHL
Tympanostomy (tympanic tube)
7.1
21.0
51
72
J39.0
ICD-10 Finland
Retropharyngeal and parapharyngeal abscess
+∞
20.8
20
*
DNW99
NOMESCO Finland
Other operation on ethmoidal sinus and bone
+∞
20.8
20
*
SPAT1057
SPAT
Peak expiratory flow measurement
2.8
20.6
139
511
G04CA01
ATC
alfuzosin; oral
1.5
20.6
854
6042
DHB30
NOMESCO Finland
Polypectomy of choana through maxillary antrum
210.5
20.6
21
*
J31
ICD-10 Finland
Chronic rhinitis, nasopharyngitis and pharyngitis
5.4
20.4
61
113
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
20.0
930
6730
Z3229
NOMESCO Finland
Other healthcare associate professional
1.6
19.9
502
3164
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
19.8
978
7156
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.9
19.7
307
1670
N03AX12
ATC
gabapentin; oral
1.5
19.7
837
5952
J01CA02
ATC
pivampicillin; oral
2.3
19.6
180
786
R51.81
ICD-10 Finland
Facial pain NOS
2.9
19.5
121
425
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
6.1
19.4
53
88
KMAK
NOMESCO Finland
NA
1.2
19.3
3228
28148
R29
ICPC
Respiratory symptom/complaint other
1.8
19.2
346
1973
C05AA08
ATC
fluocortolone; rectal, topical
1.4
19.1
829
5914
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
19.0
1623
12978
A02BC04
ATC
rabeprazole; oral
1.7
19.0
447
2767
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
18.7
1308
10147
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.8
18.7
336
1919
R49.08
ICD-10 Finland
Other specified dysphonia
3.1
18.6
104
341
A03
ICPC
Fever
1.4
18.6
821
5876
DM1BI
NOMESCO Finland
Extensive cone beam CT of paranasal sinus
38.5
18.5
23
6
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.8
18.5
118
421
DKW40
NOMESCO Finland
Ligature of artery of internal nose
14.1
18.5
31
22
DM1QA
SPAT
NA
3.0
18.3
106
355
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.8
18.3
323
1832
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.9
18.3
261
1375
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
17.6
18.2
28
16
R49.01
ICD-10 Finland
Functional dysphonia
2.5
18.1
143
578
N05BB01
ATC
hydroxyzine; systemic
1.8
18.1
334
1921
L03
ICPC
Low back symptom/complaint
1.3
18.1
1280
9946
EMA00
NOMESCO Finland
Incision of tonsil
32.9
17.9
23
7
J39.2
ICD-10 Finland
Other diseases of pharynx
8.0
17.9
40
50
J00
ICD-10 Finland
Acute nasopharyngitis [common cold]
2.8
17.9
119
436
WX402
NOMESCO Finland
General anaesthesia
1.4
17.8
980
7306
L50.8
ICD-10 Finland
Other urticaria
3.0
17.8
105
358
R03AC04
ATC
fenoterol; inhalant
5.9
17.8
49
83
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
17.7
647
4451
ZXB87
NOMESCO Finland
Balloon dilation, paranasal sinuses
+∞
17.7
17
*
50808
ICD-8 Finland
Other diseases of upper respiratory tract, Alii definiti
+∞
17.7
17
*
50306
ICD-8 Finland
Chronic sinusitis, Pansinuitis chronica
+∞
17.7
17
*
4731A
ICD-9 Finland
Chronic sinusitis, Frontal
+∞
17.7
17
*
DGW00
NOMESCO Finland
Dilatation of eustachian tube
13.7
17.7
30
22
L17
ICPC
Foot/toe symptom/complaint
1.3
17.7
1381
10890
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.3
17.6
170
762
SPAT1257
SPAT
Teaching of medicine inhalation technique
2.1
17.6
199
958
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.9
17.1
256
1372
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
7.4
17.1
40
54
E000001
ATC
NA
1.4
17.1
1117
8565
ENC30
NOMESCO Finland
Plastic operation of pharynx
3.3
17.0
86
263
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
17.0
478
3097
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
16.9
882
6510
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
7.8
16.7
38
49
DHB45
NOMESCO Finland
Turbinate reduction
63.4
16.7
19
*
4760A
ICD-9 Finland
Chronic laryngitis and laryngotracheitis, Chronic laryngitis
+∞
16.7
16
*
DPB20
NOMESCO Finland
Obliteration of frontal sinus
+∞
16.7
16
*
Z01.2
ICD-10 Finland
Dental examination
1.3
16.6
2358
20069
R81
ICPC
Pneumonia
2.1
16.6
192
932
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
16.6
497
3273
J38.4
ICD-10 Finland
Oedema of larynx
90.2
16.5
18
*
S18
ICPC
Laceration/cut
1.2
16.4
2582
22236
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
3.7
16.4
72
198
R35
ICD-10 Finland
Polyuria
1.7
16.3
374
2301
D07AB08
ATC
desonide; topical
1.5
16.3
557
3778
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
3.3
16.2
81
246
DM1AI
SPAT
NA
11.1
16.2
30
27
J01.8
ICD-10 Finland
Other acute sinusitis
6.3
16.0
42
67
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.6
16.0
407
2573
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.4
15.9
702
5023
N01
ICPC
Headache
1.6
15.9
423
2705
J01MA01
ATC
ofloxacin; systemic
1.5
15.8
494
3283
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
14.5
15.8
26
18
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
6.3
15.7
41
65
H92.0
ICD-10 Finland
Otalgia
1.9
15.7
226
1197
50700
ICD-8 Finland
NA
+∞
15.6
15
*
4741A
ICD-9 Finland
Chronic disease of tonsils and adenoids, Hypertrophy of tonsils and adenoids[HYPERTROPHIA TONSILLAE PALATINAE]
+∞
15.6
15
*
395
Kela drug reimbursment
Dupilumab
26.3
15.6
21
8
ZXC10
NOMESCO Finland
Use of laser
2.4
15.5
133
565
K80
ICPC
Cardiac arrhythmia NOS
1.6
15.5
377
2355
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.5
15.5
579
4005
DKW99
NOMESCO Finland
Other procedures for control of epistaxis
8.1
15.4
34
42
H66.1
ICD-10 Finland
Chronic tubotympanic suppurative otitis media
8.1
15.4
34
42
R97
ICPC
Allergic rhinitis
3.1
15.4
83
267
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
15.4
1228
9694
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.2
15.4
154
704
M79.1
ICD-10 Finland
Myalgia
1.5
15.3
622
4380
XKD00
NOMESCO Finland
Uroflowmetry
1.3
15.2
1099
8544
L50.9
ICD-10 Finland
Urticaria, unspecified
2.1
15.2
177
864
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
17.7
15.1
23
13
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
2.8
15.1
95
340
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
15.1
795
5876
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
15.0
1036
8005
SPAT1260
SPAT
Consultation of another employee
1.3
14.9
973
7450
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
14.9
577
4020
ZFX00
NOMESCO Finland
Use of balloon dilatation
56.7
14.8
17
*
-1
NOMESCO Finland
NA
1.3
14.7
1863
15604
XQ802
NOMESCO Finland
Epicutan test
2.0
14.7
191
973
344
Kela drug reimbursment
Omalizumab
25.0
14.7
20
8
SPAT1310
SPAT
Counselling related to known health issue
1.3
14.6
1844
15437
50308
ICD-8 Finland
Chronic sinusitis, Alia definita
+∞
14.6
14
*
50303
ICD-8 Finland
Chronic sinusitis, Frontalis NUD
+∞
14.6
14
*
50500
ICD-8 Finland
NA
+∞
14.6
14
*
D01BA02
ATC
terbinafine; oral; topical
1.3
14.6
1571
12906
DHW99
NOMESCO Finland
Other operation on nose
80.2
14.6
16
*
M05BA04
ATC
alendronic acid; oral
1.6
14.6
355
2221
M02AA07
ATC
piroxicam; topical
1.2
14.5
2100
17857
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
14.5
1561
12820
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
14.4
1345
10839
D19
ICPC
Teeth/gum symptom/complaint
1.3
14.4
1432
11636
R42
ICD-10 Finland
Dizziness and giddiness
1.3
14.4
1126
8857
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
3.6
14.4
64
179
R01AC03
ATC
azelastine; nasal
6.9
14.3
35
51
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.6
14.3
341
2119
J01DC04
ATC
cefaclor; oral
3.2
14.3
73
227
TDH60
NOMESCO Finland
Removal of foreign body of nose
27.2
14.2
19
7
J34
ICD-10 Finland
Other disorders of nose and nasal sinuses
27.2
14.2
19
7
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.4
14.2
880
6678
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
3.9
14.2
57
146
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.7
14.1
275
1614
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
14.1
1478
12092
S01GX02
ATC
levocabastine; ophthalmic
1.7
14.1
290
1731
WZA90
NOMESCO Finland
Other doctors statement
1.3
14.0
1263
10131
M54.2
ICD-10 Finland
Cervicalgia
1.6
13.9
346
2177
DJW00
NOMESCO Finland
Removal of local lesion of nasal septum
30.0
13.9
18
6
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
13.8
2743
24085
D09AB01
ATC
zinc bandage without supplements; topical
2.4
13.8
119
508
J01.3
ICD-10 Finland
Acute sphenoidal sinusitis
20.0
13.7
20
10
4939A
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]
7.3
13.7
32
44
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.4
13.7
702
5162
R4110
NOMESCO Finland
Physiotherapy
1.3
13.6
1554
12835
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
13.6
1533
12640
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
13.6
1502
12359
DMB35
NOMESCO Finland
Endoscopic excision of neoplasm or another lesion from maxillary sinus
75.2
13.6
15
*
J01AA04
ATC
lymecycline; systemic
1.4
13.6
666
4858
R53
ICD-10 Finland
Malaise and fatigue
1.3
13.6
1036
8115
4230
FHL
Forehead cavity radical cutting and filling
+∞
13.5
13
*
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
140.2
13.4
14
*
R50.9
ICD-10 Finland
Fever, unspecified
1.4
13.3
760
5687
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.0
13.3
163
816
1420
FHL
Laryngomicroscopy
8.1
13.2
29
36
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.6
13.2
334
2111
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
4.3
13.1
47
109
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.7
13.1
249
1452
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
15.0
13.1
21
14
C08DA01
ATC
verapamil; systemic
1.8
13.0
210
1160
N06AX11
ATC
mirtazapine; oral
1.2
12.9
1736
14606
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.2
12.8
1921
16358
N05CF01
ATC
zopiclone; oral
1.2
12.8
1799
15210
R06AX11
ATC
astemizole; oral
2.1
12.7
140
669
SPAT1097
SPAT
Recording of ECG
1.3
12.7
833
6375
SPAT1255
SPAT
Intravenous administration of medicine
1.6
12.7
365
2382
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.2
12.7
2110
18159
L01
ICPC
Neck symptom/complaint
1.4
12.7
637
4662
R06AE08
ATC
NA
3.5
12.6
57
162
DNB00
NOMESCO Finland
External ethmoidectomy
69.9
12.6
14
*
J38.2
ICD-10 Finland
Nodules of vocal cords
32.0
12.6
16
5
J35.8
ICD-10 Finland
Other chronic diseases of tonsils and adenoids
32.0
12.6
16
5
C07AB07
ATC
bisoprolol; oral
1.2
12.5
2899
25766
4733A
ICD-9 Finland
Chronic sinusitis, Sphenoidal
+∞
12.5
12
*
K30
ICD-10 Finland
Functional dyspepsia
1.4
12.5
510
3590
Z01.7
ICD-10 Finland
Laboratory examination
1.4
12.5
572
4117
Z97.4
ICD-10 Finland
Presence of external hearing-aid
1.7
12.5
245
1443
304
Kela drug reimbursment
Dornase alfa
130.2
12.4
13
*
DNB40
NOMESCO Finland
Sublabial rhinotomy
130.2
12.4
13
*
B977, D140
ICD-10 Finland
NA
130.2
12.4
13
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
130.2
12.4
13
*
K07.60
ICD-10 Finland
Snapping jaw
1.8
12.4
203
1129
H10
ICD-10 Finland
Conjunctivitis
1.7
12.4
277
1692
L15
ICPC
Knee symptom/complaint
1.3
12.3
1054
8378
X58
ICD-10 Finland
Exposure to other specified factors
1.4
12.3
738
5569
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.6
12.3
289
1790
D02AE01
ATC
carbamide; topical
1.6
12.3
345
2240
R51
ICD-10 Finland
Headache
1.7
12.2
227
1314
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
9.6
12.2
24
25
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.6
12.2
356
2329
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.5
12.2
379
2520
J01X
ATC
OTHER ANTIBACTERIALS
4.2
12.1
45
108
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
12.1
490
3444
A01AB10
ATC
natamycin; local oral
2.1
12.1
136
658
U02
ICPC
Urinary frequency/urgency
1.4
12.1
583
4236
R03DX05
ATC
omalizumab; parenteral
26.7
12.0
16
6
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.4
12.0
494
3482
D11AH05
ATC
dupilumab; topical
21.3
12.0
17
8
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.6
11.9
281
1745
R05CB01
ATC
acetylcysteine; inhalant, oral
2.6
11.9
87
341
J38.7
ICD-10 Finland
Other diseases of larynx
13.4
11.9
20
15
H02AB09
ATC
hydrocortisone; systemic
2.2
11.9
117
534
1543
FHL
Respiratory endoscopy
46.7
11.9
14
*
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.0
11.9
139
685
F45.8
ICD-10 Finland
Other somatoform disorders
1.6
11.8
273
1685
N17
ICPC
Vertigo/dizziness
1.4
11.7
514
3667
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
2.9
11.7
68
232
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
11.7
900
7052
D11
ICPC
Diarrhoea
1.4
11.7
502
3572
46699
ICD-8 Finland
Acute bronchitis and bronchiolitis
2.3
11.6
102
442
TDA90
NOMESCO Finland
Removal wax from ear
2.6
11.6
83
323
N05CF02
ATC
zolpidem; oral
1.3
11.5
896
7028
J01DB05
ATC
cefadroxil; oral
1.7
11.5
226
1333
S29
ICPC
Skin symptom/complaint other
1.3
11.5
878
6870
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.6
11.5
276
1720
50599
ICD-8 Finland
NA
+∞
11.5
11
*
4712A
ICD-9 Finland
NA
+∞
11.5
11
*
R04
ICPC
Breathing problem other
1.9
11.4
177
966
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.1
11.4
61
198
4231
FHL
Sphenotomy
120.1
11.4
12
*
DPB10
NOMESCO Finland
Partial excision of sphenoidal sinus
120.1
11.4
12
*
N06AX21
ATC
duloxetine; oral
1.4
11.4
504
3602
D07CC01
ATC
betamethasone and antibiotics; topical
1.4
11.4
671
5047
L16
ICPC
Ankle symptom/complaint
1.4
11.4
469
3310
R03DA05
ATC
aminophylline; systemic, rectal
3.4
11.3
53
156
S02CA02
ATC
flumetasone and antiinfectives; otic
1.6
11.3
289
1832
38401
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva
10.5
11.2
21
20
WX704
NOMESCO Finland
Intubation
1.5
11.2
381
2584
M01AC06
ATC
meloxicam; systemic, rectal
1.2
11.2
2060
17869
UDQ02
NOMESCO Finland
Direct laryngoscopy
4.2
11.2
41
98
M01AH05
ATC
etoricoxib; oral
1.2
11.2
3616
32994
H29
ICPC
Ear symptom/complaint other
1.4
11.1
496
3555
DLD00
NOMESCO Finland
Reconstruction of cartilage of nose
12.7
11.1
19
15
J01GB01
ATC
tobramycin; inhalant, parenteral
20.0
11.1
16
8
J31.2
ICD-10 Finland
Chronic pharyngitis
6.8
11.1
27
40
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.4
11.1
619
4612
H93.1
ICD-10 Finland
Tinnitus
1.5
11.1
336
2220
ECB15
NOMESCO Finland
Plastic repair of oronasal or oroantral fistula
4.0
11.0
43
109
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.5
11.0
327
2154
K08.80
ICD-10 Finland
Toothache NOS
1.5
11.0
363
2449
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
1.8
10.9
171
939
CCD60
NOMESCO Finland
Transnasal dacryocystorhinostomy
4.8
10.9
35
73
M01AE02
ATC
naproxen; oral, rectal
1.2
10.9
3359
30489
DJW99
NOMESCO Finland
Other operation on septum of nose
43.3
10.9
13
*
L08
ICPC
Shoulder symptom/complaint
1.3
10.9
1004
8057
D07AA02
ATC
hydrocortisone; topical
1.3
10.9
669
5069
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.8
10.8
180
1009
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.4
10.8
648
4886
M01AB05
ATC
diclofenac; systemic, rectal
1.2
10.8
4284
39699
ENC40
NOMESCO Finland
Uvulopalatopharyngoplasty
2.7
10.8
70
258
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.5
10.8
383
2622
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.5
10.8
390
2683
R01AB01
ATC
phenylephrine; inhalant, nasal
3.3
10.7
53
163
H70.1
ICD-10 Finland
Chronic mastoiditis
5.0
10.7
33
66
M95.0
ICD-10 Finland
Acquired deformity of nose
5.4
10.7
31
58
ENA00
NOMESCO Finland
Internal incision of pharynx
21.5
10.7
15
7
L29.9
ICD-10 Finland
Pruritus, unspecified
2.1
10.7
113
534
P06
ICPC
Sleep disturbance
1.4
10.6
473
3388
R03CC03
ATC
terbutaline; systemic
2.6
10.6
77
303
I45.9
ICD-10 Finland
Conduction disorder, unspecified
3.2
10.6
54
170
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
60.1
10.6
12
*
SBB10
NOMESCO Finland
Teeth copy
1.6
10.5
269
1709
R78
ICPC
Acute bronchitis/bronchiolitis
2.1
10.5
112
532
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.2
10.5
1225
10117
4223
FHL
Outeroid etomoidectomy
+∞
10.4
10
*
DM1ZD
NOMESCO Finland
NA
+∞
10.4
10
*
K11.2
ICD-10 Finland
Sialoadenitis
1.9
10.4
151
810
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
4.1
10.4
39
96
R49.09
ICD-10 Finland
Unspecified dysphonia
3.3
10.4
51
157
A11
ICPC
Chest pain NOS
1.5
10.3
376
2590
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
12.0
10.3
18
15
UDQ22
NOMESCO Finland
Microlaryngoscopy
4.1
10.3
38
92
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.5
10.3
368
2526
GD1AD
NOMESCO Finland
Thorax CT examination
1.6
10.3
236
1458
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.8
10.3
171
960
2120A
ICD-9 Finland
Benign neoplasm of respiratory and intrathoracic organs, Nasal cavities, middle ear and accessory sinuses
23.4
10.2
14
6
G44.2
ICD-10 Finland
Tension-type headache
1.4
10.2
575
4296
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
10.2
554
4115
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.4
10.2
495
3604
R07.3
ICD-10 Finland
Other chest pain
1.4
10.2
466
3356
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.5
10.1
296
1941
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.2
10.1
1279
10653
H02
ICPC
Hearing complaint
1.4
10.1
611
4616
A03CA02
ATC
clidinium and psycholeptics; oral
1.6
10.0
287
1873
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.4
10.0
400
2811
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.4
10.0
461
3328
WZC30
NOMESCO Finland
Teaching
1.3
10.0
743
5789
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
2.2
9.9
100
462
J05AB11
ATC
valaciclovir; oral
1.3
9.9
642
4899
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
1.8
9.9
154
844
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
1.5
9.9
335
2272
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.2
9.9
1720
14814
L43.8
ICD-10 Finland
Other lichen planus
2.3
9.9
89
391
R52.9
ICD-10 Finland
Pain, unspecified
1.4
9.8
403
2843
4121
FHL
Tympanic puncture or parasentosis in general anesthesia or operating room
8.7
9.8
20
23
L50.3
ICD-10 Finland
Dermatographic urticaria
2.5
9.7
74
300
R05CB02
ATC
bromhexine; systemic
2.3
9.7
84
364
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.5
9.7
375
2614
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
9.7
549
4102
SPAT1153
SPAT
Removal of sutures
1.2
9.7
1862
16182
DHB00
NOMESCO Finland
Excision of lesion of external nose
2.8
9.7
58
205
H60.3
ICD-10 Finland
Other infective otitis externa
2.0
9.7
115
572
E000003
ATC
NA
1.6
9.6
218
1342
ZX112
NOMESCO Finland
Subcutaneous
2.0
9.6
122
623
3DX05
NOMESCO Finland
NA
55.0
9.6
11
*
G04BD12
ATC
mirabegron; oral
1.4
9.6
491
3607
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.5
9.6
329
2238
F29
ICPC
Eye symptom/complaint other
1.4
9.6
381
2673
E000006
ATC
NA
1.5
9.6
332
2264
7849C
ICD-9 Finland
Symptoms involving head and neck, Other symptoms involving head and neck[KUORSAUS]
2.8
9.5
58
208
F2680
NOMESCO Finland
NA
7.1
9.5
22
31
A02BA04
ATC
nizatidine; systemic
1.4
9.5
393
2778
U13
ICPC
Bladder symptom/complaint other
1.9
9.4
135
721
M48.0
ICD-10 Finland
Spinal stenosis
1.3
9.4
610
4653
A06AC51
ATC
ispaghula, combinations; systemic
1.6
9.4
232
1462
E84.1
ICD-10 Finland
Cystic fibrosis with intestinal manifestations
100.1
9.4
10
*
TGC00
NOMESCO Finland
Bronchial lavation
1.9
9.4
138
742
50609
ICD-8 Finland
Chronic laryngitis, Unspecified
+∞
9.4
9
*
2770A
ICD-9 Finland
Other and unspecified disorders of metabolism, Cystic fibrosis
+∞
9.4
9
*
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.8
9.3
159
899
K90.0
ICD-10 Finland
Coeliac disease
1.9
9.3
140
760
V01AA02
ATC
grass pollen; systemic
21.7
9.3
13
6
DFF15
NOMESCO Finland
Speech audiometry
1.6
9.3
223
1395
J30.2
ICD-10 Finland
Other seasonal allergic rhinitis
8.0
9.3
20
25
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
2.2
9.3
94
438
N06AB10
ATC
escitalopram; oral
1.3
9.3
966
7863
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
1.6
9.3
216
1340
120
Kela drug reimbursment
Hypogammaglobulinaemia
9.5
9.2
18
19
SFA00
NOMESCO Finland
Small filling
1.3
9.2
657
5091
J05AB01
ATC
aciclovir; systemic
1.2
9.2
1051
8653
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.2
9.1
1218
10197
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
9.1
1587
13651
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
9.1
901
7287
D07BC01
ATC
betamethasone and antiseptics; topical
1.3
9.1
660
5124
4611A
ICD-9 Finland
Acute sinusitis, Frontal
6.2
9.0
23
37
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.6
9.0
250
1620
H91.9
ICD-10 Finland
Hearing loss, unspecified
1.6
9.0
213
1327
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.2
9.0
1079
8931
S01GX08
ATC
ketotifen; ophthalmic
1.8
9.0
149
839
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
1.9
9.0
125
662
A07EC02
ATC
mesalazine; oral, rectal
1.5
9.0
289
1942
UJH02
NOMESCO Finland
Anoscopy
1.6
9.0
208
1292
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.4
8.9
368
2600
DM1AA
SPAT
NA
4.2
8.9
32
76
H13
ICPC
Plugged feeling ear
1.3
8.9
962
7861
ZXE20
NOMESCO Finland
More than three and less than five hours
1.3
8.9
780
6213
R03
ICPC
Wheezing
2.6
8.9
61
233
DMW99
NOMESCO Finland
Other operation on maxillary antrum
18.6
8.9
13
7
D82
ICPC
Teeth/gum disease
1.2
8.9
1877
16425
R03DB04
ATC
theophylline and adrenergics; systemic
5.7
8.9
24
42
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.3
8.9
553
4199
SPAT1081
SPAT
Cardiorespiratory global assessment
1.5
8.8
289
1950
DEB10
NOMESCO Finland
Attico-antro-mastoidectomy
7.9
8.8
19
24
UKC02
NOMESCO Finland
Cystoscopy
1.3
8.8
949
7756
L04AX01
ATC
azathioprine; systemic
1.6
8.8
216
1360
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.2
8.8
1371
11662
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.3
8.8
592
4546
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
8.8
484
3600
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.3
8.8
792
6330
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.3
8.8
814
6533
K04
ICPC
Palpitations/awareness of heart
1.6
8.8
225
1431
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.5
8.8
258
1699
H65.4
ICD-10 Finland
Other chronic nonsuppurative otitis media
6.3
8.8
22
35
G04CB02
ATC
dutasteride; oral
1.4
8.7
394
2832
M13.9
ICD-10 Finland
Arthritis, unspecified
1.4
8.7
360
2550
A92
ICPC
Allergy/allergic reaction NOS
2.0
8.6
99
489
S82
ICPC
Naevus/mole
1.3
8.6
585
4501
XG466
NOMESCO Finland
Sleep oxymetry
1.7
8.5
171
1019
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.3
8.5
770
6162
4256
FHL
Nasal or sinus tumor removal
20.0
8.5
12
6
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
1.6
8.5
236
1537
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.6
8.4
234
1520
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.5
8.4
243
1591
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.4
8.4
460
3422
H03AA01
ATC
levothyroxine sodium; systemic
1.2
8.4
1077
8975
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
7.3
8.4
19
26
E84.8
ICD-10 Finland
Cystic fibrosis with other manifestations
90.1
8.4
9
*
J38.5
ICD-10 Finland
Laryngeal spasm
90.1
8.4
9
*
DJD10
NOMESCO Finland
Closure of perforation of septum of nose
90.1
8.4
9
*
M54
ICD-10 Finland
Dorsalgia
1.3
8.4
526
3997
H66
ICD-10 Finland
Suppurative and unspecified otitis media
2.1
8.4
92
445
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.3
8.4
526
3999
4750A
ICD-9 Finland
Peritonsillar abscess[PERITONSILLITIS DIFFUSA]
+∞
8.3
8
*
50809
ICD-8 Finland
Other diseases of upper respiratory tract, Unspecified
+∞
8.3
8
*
50701
ICD-8 Finland
Hay fever, Vernalis
+∞
8.3
8
*
50210
ICD-8 Finland
Chronic pharyngitis and nasopharyngitis, Chronic nasopharyngitis
+∞
8.3
8
*
4781A
ICD-9 Finland
Other diseases of upper respiratory tract, Other diseases of nasal cavity and sinuses[MORBUS CAVI NASI ET SINUS ALIA DEFINITA]
+∞
8.3
8
*
R12
ICD-10 Finland
Heartburn
1.5
8.3
313
2174
EB1MA
NOMESCO Finland
Cephalometry with X-ray
2.2
8.3
80
367
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.3
8.3
610
4746
J01MA06
ATC
norfloxacin; oral
1.3
8.3
611
4754
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.4
8.3
392
2846
J34.0
ICD-10 Finland
Abscess, furuncle and carbuncle of nose
9.4
8.3
16
17
C07AA05
ATC
propranolol; systemic
1.2
8.2
934
7678
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.6
8.2
225
1457
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
2.6
8.2
56
214
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
4.9
8.2
25
51
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.2
8.1
1272
10816
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
1.7
8.1
161
959
A03FA02
ATC
cisapride; oral, rectal
1.4
8.1
346
2463
H57.1
ICD-10 Finland
Ocular pain
1.8
8.1
134
755
SPAT1254
SPAT
Administration of medicine
1.3
8.1
716
5705
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.4
8.1
398
2905
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.4
8.1
467
3500
M01AX17
ATC
nimesulide; oral
1.2
8.1
1310
11181
J01XB01
ATC
colistin; inhalant, parenteral
33.4
8.1
10
*
M70.6
ICD-10 Finland
Trochanteric bursitis
1.3
8.1
483
3644
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
1.7
8.0
144
832
R60.0
ICD-10 Finland
Localized oedema
1.3
8.0
523
3998
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.3
8.0
649
5112
ZXC35
NOMESCO Finland
Use of radio waves
6.8
8.0
19
28
DKW10
NOMESCO Finland
Packing of anterior cavity of nose
4.4
8.0
27
61
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.0
8.0
98
494
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.3
8.0
582
4520
L02
ICPC
Back symptom/complaint
1.4
8.0
384
2796
R03BA07
ATC
mometasone; inhalant
2.9
8.0
46
158
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
1.8
7.9
122
670
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
1.4
7.9
340
2428
R03BB07
ATC
umeclidinium bromide; inhalant
2.8
7.8
46
162
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
7.8
2258
20245
K07.4
ICD-10 Finland
Malocclusion, unspecified
2.3
7.8
70
310
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.3
7.8
571
4439
38402
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita
8.4
7.8
16
19
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
1.9
7.8
103
539
D01
ICPC
Abdominal pain/cramps general
1.4
7.7
446
3351
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
1.9
7.7
102
532
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.3
7.7
518
3985
S21
ICPC
Skin texture symptom/complaint
1.3
7.7
611
4806
I10
ICD-10 Finland
Essential (primary) hypertension
1.1
7.7
3625
33660
E000007
ATC
NA
1.5
7.7
245
1649
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.5
7.6
226
1493
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.4
7.6
382
2806
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
8.0
7.6
16
20
L12
ICPC
Hand/finger symptom/complaint
1.3
7.6
661
5268
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.3
7.5
441
3316
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
2.0
7.5
90
451
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.4
7.5
401
2970
C09CA01
ATC
losartan; oral
1.2
7.5
1330
11436
XA420
NOMESCO Finland
Extensive sleep examination
2.3
7.5
65
282
D01AC02
ATC
miconazole; topical
1.4
7.5
418
3120
C09CA06
ATC
candesartan; oral
1.2
7.5
1127
9543
WX725
NOMESCO Finland
Noninvasive ventilation
1.5
7.5
228
1518
L05
ICPC
Flank/axilla symptom/complaint
1.5
7.5
246
1666
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.4
7.5
342
2468
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.5
7.5
214
1406
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.4
7.4
381
2807
C05AA01
ATC
hydrocortisone; rectal, topical
1.5
7.4
257
1759
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
2.2
7.4
68
306
D36.7
ICD-10 Finland
Benign neoplasm: Other specified sites
4.4
7.4
25
57
J39.9
ICD-10 Finland
Disease of upper respiratory tract, unspecified
4.4
7.4
25
57
DCW00
NOMESCO Finland
Removal of ventilating tube from tympanic membrane
80.1
7.4
8
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.4
7.4
356
2594
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
1.8
7.4
114
631
EBA10
NOMESCO Finland
Surgical removal of tooth
1.3
7.4
543
4228
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
1.7
7.4
155
942
WX722
NOMESCO Finland
PEEP
1.5
7.3
244
1657
SDA02
NOMESCO Finland
Parodonthologic therapy
1.2
7.3
1751
15450
50702
ICD-8 Finland
Hay fever, Aestivalis
+∞
7.3
7
*
J30.1
ICD-10 Finland
Allergic rhinitis due to pollen
+∞
7.3
7
*
TDP05
NOMESCO Finland
Puncture of frontal sinus
+∞
7.3
7
*
H60.8
ICD-10 Finland
Other otitis externa
1.8
7.3
124
705
ZYC01
NOMESCO Finland
Remote contact by phone
1.5
7.3
204
1330
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
1.5
7.3
271
1883
XCK10
NOMESCO Finland
Photography of fundus of eye
1.3
7.3
525
4074
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
2.0
7.3
91
468
L82
ICD-10 Finland
Seborrhoeic keratosis
1.3
7.2
764
6227
ZXD05
NOMESCO Finland
Urgent procedure
1.2
7.2
1743
15387
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
2.5
7.2
51
201
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.2
7.2
1054
8898
S61.0
ICD-10 Finland
Open wound of finger(s) without damage to nail
1.3
7.2
468
3579
SPAT1301
SPAT
No procedures
1.2
7.2
1745
15414
XG460
NOMESCO Finland
Short time oxymetry
2.0
7.2
81
399
N04BC05
ATC
pramipexole; oral
1.4
7.2
334
2419
J02.0
ICD-10 Finland
Streptococcal pharyngitis
2.3
7.2
61
266
R49.03
ICD-10 Finland
Atrophic dysphonia
2.6
7.2
47
178
EB1AA
SPAT
NA
1.5
7.1
221
1477
RK320
NOMESCO Finland
NA
2.6
7.1
50
195
B01AC04
ATC
clopidogrel; oral
1.2
7.1
867
7183
DC1AD
NOMESCO Finland
Temporalbone CT
2.3
7.1
58
248
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.6
7.1
193
1252
J01EA01
ATC
trimethoprim; systemic
1.2
7.1
1119
9515
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.4
7.1
293
2078
L30.8
ICD-10 Finland
Other specified dermatitis
1.8
7.1
104
566
S01GX05
ATC
lodoxamide; ophthalmic
2.4
7.1
57
241
SPAT1104
SPAT
Monitoring of emergency patient
1.4
7.1
330
2390
1450
FHL
Otomicroscopy
7.9
7.1
15
19
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
2.1
7.1
76
368
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
2.8
7.1
42
150
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.3
7.1
671
5401
R4110
SPAT
NA
1.7
7.1
128
746
WX320
NOMESCO Finland
Spinalanesthesy
1.2
7.1
1220
10466
H53.1
ICD-10 Finland
Subjective visual disturbances
1.4
7.0
275
1929
N06AB04
ATC
citalopram; systemic
1.2
7.0
1084
9196
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
8.8
7.0
14
16
L20
ICD-10 Finland
Atopic dermatitis
1.9
7.0
95
502
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.3
7.0
418
3158
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
7.0
1524
13340
A99
ICPC
Disease/condition unspecnature/site
1.4
7.0
377
2803
DAX08
NOMESCO Finland
Fitting of hearing aid
1.5
7.0
199
1308
A07EA02
ATC
hydrocortisone; rectal
1.7
6.9
123
711
U07.2
ICD-10 Finland
COVID-19, virus not identified
1.2
6.9
742
6058
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
2.4
6.9
53
219
S01GX04
ATC
nedocromil; ophthalmic
2.2
6.9
69
321
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.5
6.9
255
1770
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
3.2
6.9
34
108
DKW30
NOMESCO Finland
Cauterisation of artery of internal nose
3.0
6.9
37
125
XF600
NOMESCO Finland
Bloodpressure measurement
1.4
6.9
313
2262
99810
ICD-8 Finland
Other complications of surgical procedures, Postoperative haemorrhage or haematoma
3.5
6.8
29
82
D07XC01
ATC
betamethasone, combinations; topical
1.3
6.8
638
5126
104
Kela drug reimbursment
Thyroid insufficiency
1.4
6.8
283
2009
J98.1
ICD-10 Finland
Pulmonary collapse
2.9
6.8
37
126
H16.0
ICD-10 Finland
Corneal ulcer
1.5
6.8
224
1516
XQ820
NOMESCO Finland
Exposure to medicinal substance
4.1
6.8
24
58
WX110
SPAT
NA
1.5
6.8
209
1399
B05XA03
ATC
sodium chloride; parenteral
40.0
6.8
8
*
-
ICD-10 Finland
NA
1.8
6.7
114
650
M31.3
ICD-10 Finland
Wegener granulomatosis
4.5
6.7
22
49
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
1.8
6.7
116
666
R00.2
ICD-10 Finland
Palpitations
1.4
6.7
292
2090
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.4
6.7
289
2066
L50.0
ICD-10 Finland
Allergic urticaria
1.8
6.7
100
545
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.3
6.7
510
3988
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
1.8
6.7
112
638
L18
ICPC
Muscle pain
1.6
6.7
158
989
D02AX
ATC
Other emollients and protectives
1.7
6.7
135
813
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
0.7
6.7
204
2906
J39.1
ICD-10 Finland
Other abscess of pharynx
22.5
6.7
9
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.4
6.7
287
2054
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.1
6.7
2447
22267
H53.2
ICD-10 Finland
Diplopia
1.6
6.7
146
896
A13
ICPC
Concern/fear medical treatment
2.0
6.7
73
358
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.3
6.6
470
3642
R50
ICPC
Respiratory, Medication/prescr/renewal
4.9
6.6
20
41
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.3
6.6
525
4130
49099
ICD-8 Finland
Bronchitis, unspecified
2.3
6.6
59
261
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.3
6.6
404
3064
Z00.0
ICD-10 Finland
General medical examination
1.2
6.6
938
7895
SPAT1360
SPAT
Extensive global examination
1.4
6.6
359
2671
46104
ICD-8 Finland
Acute sinusitis, Pansinuitis
5.9
6.6
17
29
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.6
6.6
157
989
DQA10
NOMESCO Finland
Biopsy of larynx
4.0
6.6
24
60
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
1.5
6.6
199
1327
4471
FHL
Pharyngoplasty
3.2
6.5
31
96
EKA10
NOMESCO Finland
Biopsy of cheek
1.9
6.5
91
487
K02.0
ICD-10 Finland
Caries limited to enamel
1.3
6.5
590
4723
R11
ICD-10 Finland
Nausea and vomiting
1.4
6.5
326
2395
U71
ICPC
Cystitis/urinary infection other
1.5
6.5
216
1467
N05BA12
ATC
alprazolam; oral
1.3
6.5
480
3742
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
1.7
6.5
126
750
A05
ICPC
Feeling ill
1.5
6.5
219
1494
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.3
6.5
429
3292
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
2.1
6.5
64
300
46101
ICD-8 Finland
Acute sinusitis, Frontalis
5.0
6.5
19
38
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.4
6.5
345
2559
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
1.3
6.5
554
4405
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.2
6.4
948
8004
R04.2
ICD-10 Finland
Haemoptysis
1.6
6.4
167
1074
J35.3
ICD-10 Finland
Hypertrophy of tonsils with hypertrophy of adenoids
69.9
6.4
7
*
B37.0
ICD-10 Finland
Candidal stomatitis
2.6
6.4
44
173
DKW20
NOMESCO Finland
Packing of posterior cavity of nose
7.4
6.4
14
19
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.2
6.4
679
5538
XF402
NOMESCO Finland
ECG with work load test
1.3
6.4
570
4557
L11
ICPC
Wrist symptom/complaint
1.4
6.4
309
2258
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.3
6.4
474
3701
A07EA06
ATC
budesonide; oral, local oral
1.6
6.4
153
964
H01.0
ICD-10 Finland
Blepharitis
1.5
6.3
226
1559
D11AH01
ATC
tacrolimus; topical
2.8
6.3
37
131
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
2.3
6.3
57
254
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
1.8
6.3
103
583
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.3
6.3
498
3917
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.2
6.3
695
5693
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.5
6.3
218
1495
R2110
NOMESCO Finland
Giving the first information
1.4
6.3
298
2167
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
1.6
6.3
141
874
D38.50
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of maxillary sinus
11.0
6.3
11
10
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
4.0
6.3
23
58
3DX08
NOMESCO Finland
NA
+∞
6.2
6
*
4AC06
NOMESCO Finland
NA
+∞
6.2
6
*
DH_2
NOMESCO Finland
Endoscopy of nose
+∞
6.2
6
*
4784A
ICD-9 Finland
Other diseases of upper respiratory tract, Polyp of vocal cord or larynx[POLYPUS PLICAE VOCALIS]
+∞
6.2
6
*
4612A
ICD-9 Finland
Acute sinusitis, Ethmoidal
+∞
6.2
6
*
4741D
ICD-9 Finland
Chronic disease of tonsils and adenoids, Hypertrophy of tonsils and adenoids[HYPERTROPHIA TONSILLAE PALATINAE ET PHARYNGICAE]
+∞
6.2
6
*
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.3
6.2
436
3374
SPAT1283
SPAT
Restricted health certificate
1.2
6.2
722
5952
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
1.6
6.2
161
1033
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
4.3
6.2
21
49
J01AA07
ATC
tetracycline; systemic
1.2
6.2
718
5913
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.3
6.2
405
3105
A48
ICPC
General and Unspecified, Clarification/discussion RFE/demand
1.4
6.2
244
1716
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
1.7
6.2
111
647
H25.1
ICD-10 Finland
Senile nuclear cataract
1.2
6.2
1182
10224
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
1.8
6.2
105
602
S83.2
ICD-10 Finland
Tear of meniscus, current
1.3
6.2
351
2637
L20
ICPC
Joint symptom/complaint NOS
1.6
6.1
141
879
N06AA09
ATC
amitriptyline; systemic
1.3
6.1
437
3388
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.3
6.1
419
3231
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.3
6.1
492
3877
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.3
6.1
517
4105
M79.7
ICD-10 Finland
Fibromyalgia
1.7
6.1
105
605
SPAT1043
SPAT
Audiometry
1.3
6.1
498
3932
T78.3
ICD-10 Finland
Angioneurotic oedema
2.1
6.1
66
322
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
4.2
6.1
21
50
G01AF05
ATC
econazole; vaginal
1.4
6.1
276
1993
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.2
6.1
694
5707
WX400
NOMESCO Finland
Inhalation anesthesy
1.5
6.1
180
1196
D18.0
ICD-10 Finland
Haemangioma, any site
1.8
6.1
101
576
M19.8
ICD-10 Finland
Other specified arthrosis
1.6
6.1
150
952
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.5
6.1
178
1177
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
12.5
6.1
10
8
TDC10
NOMESCO Finland
Removal of ventilating tube from tympanic membrane
12.5
6.1
10
8
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
6.1
1660
14776
R49.0
ICD-10 Finland
Dysphonia
2.1
6.1
61
289
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.6
6.0
142
893
-50
ICPC
Medication/prescr/renewal
1.5
6.0
199
1353
F10.25
ICD-10 Finland
Alcohol dependence continuous use
0.4
6.0
26
621
A44
ICPC
General and Unspecified, Preventive immunization/medic
1.3
6.0
358
2706
DLD10
NOMESCO Finland
Reconstruction of cartilage and bone of nose
6.7
6.0
14
21
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
6.0
1542
13659
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005322) IgE [Units/volume] in Serum or Plasma
1333
3182
4.76
307.65
1.8
1.2
u/ml
402.4
239.3
2.34
1289
2932
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
477
825
6.06
264.03
1.2
1.1
u/ml
0.7
1.6
1.43
269
273
(3003888) Timothy IgE Ab [Units/volume] in Serum
445
725
6.41
261.57
1.2
1.0
u/ml
2.8
4.6
1.87
294
308
(3008401) Mugwort IgE Ab [Units/volume] in Serum
418
707
6.16
236.44
1.2
1.0
u/ml
0.7
1.6
1.29
245
247
(3010726) Horse dander IgE Ab [Units/volume] in Serum
404
665
6.32
234.83
1.2
1.0
u/ml
1.0
2.0
1.44
142
136
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
260
261
10.24
229.80
1.5
1.2
u/ml
1.3
1.4
0.09
173
107
(4010399)
1186
4472
2.91
223.85
1.7
1.4
—
—
—
0
0
(3000492) Spirometry study
1351
6175
2.40
169.70
1.7
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1552
7732
2.22
158.33
2.0
1.8
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
305
597
5.26
147.09
1.2
1.0
u/ml
4.0
3.3
0.24
173
206
(3013115) Eosinophils [#/volume] in Blood
4756
35177
1.77
143.96
6.6
6.2
e9/l
0.3
0.2
172.41
4195
30824
(3023430) Cat dander IgE Ab [Units/volume] in Serum
288
553
5.35
141.89
1.1
1.0
u/ml
3.4
3.3
0.06
163
188
(40768804) Tissue Pathology biopsy report
3896
27316
1.77
141.01
2.2
2.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
255
488
5.35
126.04
1.1
1.0
u/ml
0.3
0.8
0.41
101
84
(3006315) Basophils [#/volume] in Blood
4550
34138
1.69
122.57
6.4
6.0
e9/l
0.0
0.0
30.76
3978
29460
(3001604) Monocytes [#/volume] in Blood
4525
33961
1.69
121.22
6.4
5.9
e9/l
0.6
0.6
0.30
3955
29307
(3019198) Lymphocytes [#/volume] in Blood
4613
34961
1.68
117.65
6.5
6.0
e9/l
1.9
1.9
0.05
4092
30677
(3042936) Bacteria identified in Isolate by Culture
1693
9896
1.88
106.68
2.0
2.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
4238
32054
1.63
103.78
6.8
6.5
%
8.6
8.8
6.39
4013
30071
(3006504) Eosinophils/100 leukocytes in Blood
4218
31896
1.62
103.15
6.6
6.2
%
4.4
2.8
150.97
3980
29798
(3013650) Neutrophils [#/volume] in Blood by Automated count
5014
39613
1.62
101.92
8.9
9.5
e9/l
4.2
4.2
0.43
4392
34601
(3018010) Neutrophils/100 leukocytes in Blood
4260
32387
1.61
101.17
6.5
6.1
%
56.5
57.7
9.01
4021
30323
(3022096) Basophils/100 leukocytes in Blood
4109
30972
1.62
101.07
6.6
6.2
%
0.7
0.7
19.09
3881
28953
(3002030) Lymphocytes/100 leukocytes in Blood
4304
32890
1.61
99.39
6.7
6.3
%
27.0
27.3
1.34
4048
30654
(3013707) Erythrocyte sedimentation rate by Westergren method
6076
50609
1.66
97.44
4.6
3.9
mm/h
11.8
12.3
1.99
5697
46800
(42870588) Differential panel, method unspecified - Blood
3222
23193
1.62
93.65
6.2
6.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
235
576
4.16
85.85
1.7
1.3
g/l
0.3
0.4
4.53
192
385
(3028192) IgG subclass 2 [Mass/volume] in Serum
235
576
4.16
85.85
1.7
1.3
g/l
3.0
3.0
0.06
192
387
(3027135) IgG subclass 1 [Mass/volume] in Serum
235
577
4.16
85.65
1.7
1.3
g/l
6.4
7.3
2.59
193
385
(4062490)
232
575
4.12
83.50
1.7
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
303
971
3.20
74.20
1.9
1.6
g/l
1.1
0.8
2.22
252
721
(3000494) Fungus identified in Specimen by Culture
1307
7849
1.78
72.66
1.7
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
7717
70256
1.84
71.56
16.1
14.3
mg/l
23.7
25.4
3.72
6408
55747
(3009445) Proteinase 3 Ab [Units/volume] in Serum
612
2926
2.17
66.12
1.6
1.5
u/ml
16.5
13.2
0.13
14
72
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
500
2273
2.27
61.04
1.7
1.6
titre
143.5
311.3
1.40
17
91
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
63
62
10.23
56.34
1.3
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
234
791
3.01
52.30
4.1
2.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6104
54108
1.42
47.53
7.7
7.8
u/l
76.0
79.0
4.82
5790
51022
(40768797) Stomach Pathology biopsy report
1327
8921
1.57
46.00
1.3
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
6897
62765
1.47
44.70
4.8
4.3
mu/l
2.3
2.2
0.03
6394
57262
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
93
185
5.07
44.09
1.1
1.0
u/ml
7.2
9.5
0.18
26
22
(44813793)
128
329
3.93
43.93
1.1
1.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
68
101
6.78
43.58
1.1
1.0
u/ml
6.5
12.5
—
11
10
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
4870
41876
1.37
43.26
3.1
2.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
5756
50888
1.38
42.68
4.0
3.6
pmol/l
14.8
14.8
0.21
5305
46227
(3037467) Urinalysis macro (dipstick) panel - Urine
5372
47154
1.36
40.43
4.4
4.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
5099
44423
1.35
40.14
4.4
4.2
e6/l
232.1
1194.9
2.93
85
678
(3019550) Sodium [Moles/volume] in Serum or Plasma
7791
73109
1.60
40.07
17.5
16.6
mmol/l
139.7
139.7
2.20
7638
71329
(3023103) Potassium [Moles/volume] in Serum or Plasma
7805
73366
1.59
38.73
17.6
16.8
mmol/l
4.0
4.0
7.95
7637
71449
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1477
10508
1.49
38.72
1.3
1.3
iu/ml
31.9
36.3
0.56
456
3325
(40761511) CBC panel - Blood by Automated count
7818
73599
1.59
37.58
14.2
13.5
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
373
1830
2.08
37.42
1.8
1.4
iu/ml
11.2
13.4
0.19
13
34
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1388
9820
1.49
37.26
1.3
1.2
u/ml
12.8
13.2
0.08
510
3891
(3007164) IgA [Mass/volume] in Serum or Plasma
1628
11915
1.45
36.67
1.5
1.5
g/l
2.5
2.6
0.27
1008
7409
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3352
27856
1.33
34.17
2.0
2.0
pmol/l
95.5
93.9
1.18
1773
15091
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1913
14573
1.40
34.12
1.7
1.8
mg/l
1.1
1.3
1.82
1474
11249
(40758558) Short blood count panel - Blood
2232
17547
1.37
32.59
6.7
7.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
3658
30917
1.31
32.56
9.5
9.9
e9/l
0.0
0.0
1.39
2928
25507
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
7199
67097
1.41
31.86
14.1
13.5
ml/min/173m2
81.6
80.8
2.90
6026
55659
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
166
614
2.74
31.56
5.3
3.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3197
26601
1.32
31.55
2.4
2.2
nmol/l
77.8
76.2
2.41
2900
23960
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3973
34066
1.30
31.41
6.5
7.1
mmol/l
1.2
1.2
7.32
3436
28680
(3020564) Creatinine [Moles/volume] in Serum or Plasma
7972
75871
1.57
30.99
17.9
16.8
umol/l
79.4
80.7
2.86
7972
75838
(3048689) Calprotectin [Mass/mass] in Stool
1057
7328
1.50
30.89
2.5
2.3
ug/g
119.4
144.8
2.44
882
5854
(3007461) Platelets [#/volume] in Blood
8235
79040
1.72
30.50
23.3
20.9
e9/l
252.3
245.7
16.72
8057
76991
(3035941) MCH [Entitic mass]
8236
79082
1.71
30.06
23.1
20.8
pg
30.4
30.4
1.42
8133
77949
(3010813) Leukocytes [#/volume] in Blood
8238
79117
1.71
29.90
23.3
20.9
e9/l
7.0
6.7
14.58
8035
76790
(3026361) Erythrocytes [#/volume] in Blood
8236
79100
1.71
29.79
23.3
20.9
e12/l
4.6
4.5
3.62
8038
76796
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
244
1112
2.23
29.57
1.8
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
8234
79092
1.70
29.55
23.2
20.8
fl
91.2
91.1
0.12
8132
77955
(3005719) IgG [Mass/volume] in Serum or Plasma
772
5043
1.58
29.53
2.9
2.6
g/l
10.4
10.8
1.29
729
4589
(3000963) Hemoglobin [Mass/volume] in Blood
8236
79123
1.70
29.45
23.4
21.0
g/l
137.4
137.0
2.00
8139
77975
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3320
27981
1.30
29.11
2.9
2.8
ug/l
129.7
153.8
5.87
3072
25885
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1337
9814
1.43
28.92
1.5
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3629
30967
1.29
28.87
5.8
6.3
mmol/l
1.2
1.2
5.95
3296
28164
(3013826) Glucose [Moles/volume] in Serum or Plasma
4724
41749
1.29
28.35
4.7
4.9
mmol/l
6.7
6.8
4.53
4458
39108
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
302
1523
2.02
28.13
1.4
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
7040
65704
1.37
28.10
6.0
5.8
mmol/mol
40.1
40.1
0.05
6578
60990
(3037522) Nuclear Ab [Titer] in Serum
1192
8631
1.44
27.69
1.3
1.3
titre
487.0
521.0
0.25
229
1753
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
7954
75918
1.53
27.60
11.1
10.3
u/l
26.9
27.6
2.86
7711
73276
(3003327) Ova and parasites identified in Stool by Light microscopy
352
1884
1.90
27.58
1.8
1.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
857
5819
1.52
27.49
2.5
2.3
nmol/l
339.0
376.5
4.88
782
5371
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1712
13271
1.36
26.50
1.3
1.2
u/ml
2.0
1.9
0.07
437
3668
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
7306
68769
1.38
26.21
4.8
4.5
mmol/l
6.0
6.0
2.73
6717
62968
(3022145) Colonoscopy Study observation
1076
7757
1.44
25.45
1.4
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
53
105
5.07
25.35
1.1
1.1
u/ml
2.8
2.0
0.12
27
41
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
281
1436
1.99
25.24
1.2
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
45
77
5.87
25.19
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
629
4093
1.58
24.34
1.2
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4151
36558
1.26
23.74
6.0
6.6
umol/l
11.2
11.9
4.35
3946
34794
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
3122
26711
1.26
22.50
3.7
3.6
ng/l
35.2
65.4
2.91
2163
18850
(40760892) CBC W Ordered Manual Differential panel - Blood
1878
15093
1.31
22.15
4.9
4.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
256
1329
1.95
22.01
1.3
1.2
titre
44.0
103.0
—
5
20
(4015189)
63
161
3.93
21.97
2.5
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
6298
58510
1.27
21.56
18.9
17.5
%
13.7
13.7
0.23
6209
57270
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1438
11172
1.34
21.41
1.9
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
7566
72105
1.37
21.09
5.2
4.9
mmol/l
2.7
2.7
0.19
7013
66697
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2596
21859
1.27
21.06
2.6
2.7
u/l
56.2
58.4
1.41
2415
20232
(3028026) IgM [Mass/volume] in Serum or Plasma
596
3964
1.54
20.89
1.8
1.9
g/l
1.2
1.4
1.09
547
3603
(3018418) pH of Serum or Plasma
2419
20212
1.27
20.88
4.0
4.3
ph
7.4
7.4
0.03
360
4012
(3044889) 12 lead EKG panel
5498
50355
1.25
20.87
4.0
3.7
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
30
41
7.34
20.75
1.5
1.5
umol/l
52.5
44.3
0.45
30
41
(3019420) Tryptase [Mass/volume] in Serum or Plasma
86
280
3.09
20.74
1.4
1.4
ug/l
8.6
7.7
0.20
78
257
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1698
13591
1.31
20.41
3.9
3.8
ng/l
302.3
620.4
2.86
1322
10816
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
449
2825
1.62
19.98
2.1
1.9
u/l
38.6
39.2
0.29
407
2474
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
24
26
9.25
19.96
1.7
1.7
mg/l
1.7
2.5
0.21
17
14
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1034
7716
1.39
19.79
1.8
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2377
19926
1.26
19.75
2.8
3.0
ng/l
1246.7
1481.2
1.92
2041
17223
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
169
785
2.18
19.67
1.1
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2059
16986
1.28
19.48
2.3
2.2
mg/l
2.8
3.0
1.58
1754
14523
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1034
7765
1.38
19.00
1.9
1.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
253
1376
1.86
18.95
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
253
1376
1.86
18.95
1.4
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
2871
24697
1.24
18.79
3.8
3.6
e6/l
68.6
96.0
0.90
2073
17875
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
7424
70788
1.32
18.71
4.7
4.4
mmol/l
4.6
4.6
0.20
6920
65905
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
314
1833
1.74
18.58
2.0
1.9
mg/l
10.6
11.6
1.58
297
1707
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
23
26
8.87
18.53
1.7
1.7
mg/l
1.5
1.2
0.15
14
12
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
23
26
8.87
18.53
1.7
1.7
mg/l
1.3
1.4
—
18
10
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
23
26
8.87
18.53
1.7
1.7
mg/l
1.8
1.0
0.30
14
13
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
23
26
8.87
18.53
1.7
1.7
mg/l
3.8
1.5
0.83
18
14
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
23
26
8.87
18.53
1.7
1.7
mg/l
2.0
0.9
0.47
17
12
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
23
26
8.87
18.53
1.7
1.7
mg/l
1.1
0.3
0.78
16
13
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
23
26
8.87
18.53
1.7
1.7
mg/l
4.0
3.2
—
18
10
(3024561) Albumin [Mass/volume] in Serum or Plasma
3435
30157
1.23
18.47
4.9
5.2
g/l
35.6
35.3
2.52
3223
28092
(3003338) MCHC [Mass/volume]
6446
60420
1.25
18.40
20.5
18.2
g/l
332.7
333.0
2.81
6403
59978
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
3713
32892
1.22
18.21
3.8
4.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
7372
70288
1.31
18.10
4.6
4.4
mmol/l
1.4
1.4
2.55
6837
65071
(3014599) Egg white IgE Ab [Units/volume] in Serum
84
293
2.89
18.01
1.0
1.0
u/ml
3.5
0.3
0.68
25
50
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
23
27
8.54
18.00
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
163
776
2.12
17.86
1.2
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
5162
47335
1.22
17.72
3.1
3.1
u/l
49.1
51.8
1.13
4844
44162
(3011397) Hemoglobin [Presence] in Urine by Test strip
1900
15681
1.27
17.64
3.6
3.5
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
19
18
10.58
17.32
1.1
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
660
4662
1.45
17.17
1.2
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
2320
19659
1.25
17.04
4.6
4.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1491
12025
1.29
16.53
2.7
2.8
e6/l
0.7
1.1
7.48
865
6913
(36304419) Bacteria [Presence] in Urine
2244
19000
1.24
16.51
3.1
3.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
3766
33620
1.21
16.50
3.6
3.5
estimate
0.0
0.0
0.80
597
6258
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
382
2424
1.60
16.44
2.7
2.5
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2484
21284
1.23
16.33
2.2
2.2
u/l
186.0
239.6
2.04
2347
19995
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
7136
67959
1.27
16.23
4.2
4.0
mmol/l
1.3
1.3
3.55
6581
62505
(3020874) Milk IgE Ab [Units/volume] in Serum
80
288
2.79
16.22
1.0
1.0
u/ml
0.5
2.0
0.45
26
57
(3009542) Hematocrit [Volume Fraction] of Blood
6823
64644
1.25
16.18
17.2
15.2
%
40.7
40.1
8.25
5026
46274
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
164
813
2.04
16.18
1.2
1.1
au/ml
21.3
8.2
—
6
41
(3015076) Soybean IgE Ab [Units/volume] in Serum
73
254
2.89
15.77
1.0
1.0
u/ml
0.3
2.9
—
9
30
(3009261) Glucose [Presence] in Urine by Test strip
3797
34029
1.20
15.67
3.7
3.5
estimate
0.0
0.0
0.10
613
6158
(3002582) Erythrocytes [#/volume] in Urine
2503
21585
1.22
15.24
3.3
3.2
e6/l
54.6
91.3
1.59
1915
16710
(3021601) Nitrite [Presence] in Urine by Test strip
3751
33652
1.20
15.11
4.9
4.6
estimate
0.0
0.0
0.43
624
6393
(3030467) Casts [#/volume] in Urine by Automated count
2306
19753
1.23
14.93
3.2
3.1
e6/l
0.3
0.4
1.37
1726
14936
(3021960) Folate [Moles/volume] in Serum or Plasma
1875
15759
1.24
14.44
1.6
1.5
nmol/l
20.1
19.8
0.42
1644
13555
(3026493) Urate [Moles/volume] in Serum or Plasma
2250
19348
1.22
13.83
2.7
2.7
umol/l
2953.5
4593.2
1.39
1951
16918
(3024891) Influenza virus A+B Ag [Presence] in Specimen
268
1635
1.66
13.57
1.2
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
429
2920
1.49
13.49
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
858
6596
1.33
13.34
2.3
2.2
nmol/l
13.1
12.8
0.50
764
5899
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
297
1869
1.61
13.29
1.5
1.6
g/l
0.2
0.2
0.16
284
1766
(1002224) Polysomnography panel
421
2864
1.49
13.28
1.1
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
44
127
3.48
13.01
1.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
277
1723
1.63
13.00
1.2
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
713
5354
1.36
12.95
1.4
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
275
1711
1.63
12.90
1.8
1.9
pmol/l
195.5
200.2
0.37
265
1627
(3014765) Yersinia sp identified in Stool by Organism specific culture
278
1735
1.62
12.88
1.2
1.2
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
16
18
8.90
12.88
1.0
1.0
u/ml
0.5
0.1
—
10
11
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
427
2936
1.48
12.78
1.1
1.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1768
14943
1.23
12.71
2.6
2.6
e6/l
3.9
4.7
3.14
1545
13111
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
3595
32455
1.18
12.70
5.0
4.8
ug/l
3.4
3.5
0.03
3248
29203
(42529406) Shigella sp [Presence] in Stool by Culture
278
1745
1.61
12.59
1.2
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
302
1937
1.58
12.50
1.5
1.6
g/l
1.2
1.2
0.87
289
1839
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
2913
25893
1.19
12.20
4.4
4.2
%
21.7
21.9
0.29
1398
12587
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
598
4410
1.38
12.16
2.4
2.3
au/ml
20.5
23.7
0.29
31
251
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
91
403
2.27
12.07
2.3
2.8
e9/l
0.3
0.2
0.09
71
357
(4094501)
300
1942
1.56
11.94
1.1
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
256
1599
1.62
11.85
1.2
1.3
u/ml
9.6
31.5
—
7
98
(3019150) Specific gravity of Urine by Refractometry
1725
14660
1.22
11.62
4.0
3.9
kg/l
1.0
1.0
0.15
235
2174
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
547
4005
1.39
11.62
1.3
1.3
au/ml
40.3
52.6
0.51
20
183
(3033658) Prothrombin time (PT) actual/Normal
2103
18222
1.20
11.59
3.9
4.1
%
89.8
88.2
2.28
2063
17801
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1360
11278
1.24
11.57
2.9
3.0
e6/l
2.0
1.9
0.06
747
6206
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
76
319
2.39
11.42
1.1
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
45
145
3.11
11.22
1.8
2.3
e6/l
252.8
739.6
0.50
18
77
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
350
2377
1.49
11.18
1.7
1.7
nmol/l
39.9
41.3
0.62
340
2305
(3013005) Retinol [Moles/volume] in Serum or Plasma
59
223
2.66
11.03
2.8
1.6
umol/l
2.0
1.9
0.26
53
209
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
91
423
2.16
10.78
2.2
2.7
e6/l
590.6
492.0
1.15
69
360
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
817
6425
1.30
10.75
2.5
2.6
u/l
36.4
39.2
0.40
692
5530
(3026389) Candida sp identified in Specimen by Organism specific culture
150
837
1.81
10.54
1.4
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
236
1495
1.59
10.36
1.2
1.3
u/ml
3.0
7.7
2.50
29
250
(3017732) Neutrophils [#/volume] in Blood
610
4638
1.34
10.21
2.6
3.1
e9/l
4.4
4.1
1.18
479
3621
(3013512) EKG study
2295
20259
1.18
9.99
3.9
3.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1436
12158
1.22
9.89
2.8
3.3
mmol/l
2.4
2.5
0.29
1260
10670
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
277
1843
1.52
9.81
1.7
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2607
23290
1.17
9.75
3.2
3.3
u/l
31.6
35.6
2.24
2486
22083
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1928
16808
1.19
9.67
2.3
2.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
230
1476
1.57
9.59
1.2
1.3
u/ml
2.3
5.8
1.00
20
158
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1010
8268
1.25
9.55
4.5
4.5
%
32.1
31.9
0.28
715
5648
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
2112
18574
1.18
9.54
3.1
2.9
ug/l
0.7
0.8
5.90
1387
12280
(3015377) Calcium [Moles/volume] in Serum or Plasma
2524
22529
1.17
9.49
3.2
3.6
mmol/l
2.3
2.3
0.55
2210
19766
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
23
53
4.35
9.31
1.1
1.1
u/ml
2.2
0.0
0.69
15
37
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
321
2226
1.46
9.29
1.7
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
2471
22059
1.17
9.22
2.3
2.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
481
3589
1.36
9.13
3.2
3.3
pmol/l
4.5
4.4
0.56
428
3174
(3008898) HLA-B27 [Presence]
287
1968
1.47
8.82
1.1
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
36
118
3.06
8.79
1.4
2.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
243
1612
1.52
8.77
1.6
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
246
1639
1.52
8.70
1.6
1.6
e6/l
10310.0
16227.1
1.06
183
1182
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
23
56
4.12
8.70
1.0
1.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
529
4038
1.33
8.64
1.7
1.7
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
92
481
1.92
8.03
1.7
1.6
u/ml
27.1
26.3
0.05
22
114
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
193
1243
1.57
8.00
1.2
1.3
u/ml
8.4
4.5
0.21
15
96
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
970
8059
1.23
7.97
2.7
2.9
umol/l
7.0
9.4
4.17
854
7091
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
2093
18623
1.16
7.94
1.7
1.6
mmol/l
1.3
1.4
2.99
1797
15512
(3025018) Bordetella pertussis Ab [Titer] in Serum
60
269
2.24
7.88
1.3
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
181
1153
1.58
7.87
1.2
1.3
u/ml
27.7
38.4
0.43
15
115
(3025941) Bacteria identified in Stool by Culture
469
3578
1.33
7.72
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
464
3541
1.33
7.62
2.5
2.4
—
—
—
0
0
(3019225) pH of Specimen
794
6488
1.25
7.61
3.9
4.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
323
2335
1.40
7.50
1.2
1.2
u/ml
0.5
1.0
0.85
34
217
(3042631) Mycobacterium sp identified in Specimen
157
980
1.61
7.46
2.9
2.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
728
5906
1.25
7.44
2.8
3.0
ng/l
141.9
211.2
8.93
660
5384
(3004716) Salmonella sp identified in Stool by Organism specific culture
390
2916
1.35
7.36
1.4
1.4
—
—
—
0
0
(44790048)
129
770
1.69
7.30
1.7
1.4
—
—
—
0
0
(44790047)
129
770
1.69
7.30
1.7
1.4
—
—
—
0
0
(44790049)
129
770
1.69
7.30
1.7
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1024
8628
1.21
7.30
6.9
7.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
68
331
2.06
7.30
4.4
3.8
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
100
555
1.81
7.30
1.2
1.2
titre
158.0
214.4
0.36
20
98
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
63
298
2.12
7.28
1.1
1.1
iu/ml
7.8
10.7
0.54
19
79
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
187
1224
1.54
7.25
1.5
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
3202
29517
1.13
7.12
8.8
9.5
inr
1.3
1.3
0.15
842
8520
(3002256) Pathology report gross observation
1063
9012
1.20
7.10
1.3
1.3
—
—
—
0
0
(44806118)
128
770
1.67
7.05
1.7
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
229
1574
1.47
7.04
1.1
1.1
u/ml
2.0
9.0
4.05
15
196
(3026782) Osmolality of Urine
1584
13936
1.17
6.85
2.9
2.7
mosm/kgh2o
564.5
562.5
0.13
1349
11913
(3022948) Iron [Moles/volume] in Serum or Plasma
1297
11228
1.18
6.84
2.4
2.6
umol/l
28.7
13.0
0.49
1208
10427
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
146
916
1.60
6.83
1.2
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
85
461
1.85
6.71
1.1
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
516
4069
1.28
6.69
1.5
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2865
26323
1.13
6.58
3.9
3.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
610
4923
1.26
6.54
1.8
1.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
108
638
1.70
6.41
2.1
2.5
e9/l
1.4
1.1
2.34
60
403
(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum
10
15
6.67
6.31
1.0
1.0
u/ml
6.8
0.1
—
5
6
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
666
5454
1.24
6.28
1.8
1.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
752
6240
1.22
6.25
2.2
2.3
ug/l
7.3
8.0
0.35
672
5497
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
75
403
1.87
6.13
1.5
1.3
titre
20.0
65.5
—
7
38
(3044941) Cell count panel - Synovial fluid
160
1054
1.53
6.10
1.4
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
257
1864
1.39
5.94
1.5
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1209
10525
1.17
5.93
1.7
1.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
283
2086
1.37
5.93
3.0
3.4
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
76
415
1.84
5.92
1.5
1.3
titre
309.1
396.2
0.16
11
34
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
27
95
2.85
5.92
1.1
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
27
95
2.85
5.92
1.1
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
27
95
2.85
5.92
1.1
1.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
15
36
4.17
5.81
1.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1426
12595
1.16
5.79
1.8
1.8
nmol/l
1126.7
1159.8
0.64
1066
9600
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
148
971
1.53
5.77
1.5
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
2071
18783
1.13
5.70
3.0
3.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
46
213
2.17
5.70
1.6
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
478
3813
1.27
5.69
1.2
1.2
iu/ml
133.0
144.1
0.26
179
1396
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
87
502
1.74
5.67
1.8
2.1
%
12.6
15.8
1.71
57
204
(3000570) Elastase.pancreatic [Mass/mass] in Stool
262
1925
1.37
5.62
1.4
1.4
ug/g
290.6
260.6
1.62
145
1127
(3027945) Reticulocytes/100 erythrocytes in Blood
954
8179
1.19
5.62
2.3
2.5
%
1.7
1.8
0.48
845
7276
(3009214) Lutropin [Units/volume] in Serum or Plasma
243
1774
1.38
5.44
1.4
1.4
u/l
9.6
9.5
0.05
208
1464
(3009508) Creatinine [Moles/volume] in Urine
2498
22991
1.12
5.34
3.1
3.3
mmol/l
8.0
8.0
0.28
2121
19343
(3020961) Endomysium IgA Ab [Titer] in Serum
360
2802
1.30
5.23
1.1
1.1
titre
181.4
239.5
—
7
87
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
586
4830
1.23
5.23
1.7
1.7
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
16
44
3.64
5.19
1.6
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
224
1627
1.39
5.19
1.7
1.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
120
772
1.56
5.16
2.1
2.2
mg/l
22.3
26.1
0.31
32
206
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
82
479
1.72
5.15
1.9
2.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
867
7432
1.18
5.12
1.6
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
229
1678
1.37
5.04
1.7
1.6
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
41
193
2.13
4.92
1.2
1.2
g/l
0.3
0.3
0.04
34
154
(3022313) Gas panel - Capillary blood
396
3146
1.27
4.92
3.2
3.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
84
501
1.68
4.91
1.8
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1185
10446
1.16
4.91
2.3
2.6
g/l
2.3
2.3
0.88
1102
9698
(3021440) Promyelocytes/100 leukocytes in Blood
680
5730
1.20
4.87
4.3
4.2
%
0.1
0.1
0.10
201
1666
(3017181) Myelocytes/100 leukocytes in Blood
714
6045
1.20
4.86
4.2
4.2
%
0.8
1.0
1.32
213
1793
(3003740) Influenza virus B Ag [Presence] in Specimen
141
956
1.48
4.78
1.1
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
103
654
1.58
4.72
1.7
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
1090
9583
1.16
4.68
25.6
25.2
inr
1.4
1.4
0.12
157
1330
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
45
224
2.01
4.68
1.0
1.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1113
9806
1.15
4.65
2.4
2.7
%
22.6
23.0
0.55
955
8392
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
109
704
1.56
4.65
1.7
1.7
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
46
232
1.99
4.62
1.8
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
140
956
1.47
4.60
1.1
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
981
8576
1.16
4.55
6.9
7.6
mmol/l
1.2
1.0
1.10
741
6708
(3027801) Oxygen [Partial pressure] in Arterial blood
982
8597
1.16
4.47
6.9
7.6
kpa
12.1
12.4
0.90
930
8199
(3014576) Chloride [Moles/volume] in Serum or Plasma
1060
9336
1.15
4.45
6.8
7.3
mmol/l
104.6
104.5
0.28
1029
9124
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
22
82
2.69
4.40
1.1
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
981
8604
1.16
4.36
6.9
7.6
kpa
5.1
5.1
0.25
928
8214
(40761535) Cells panel - Urine sediment
673
5728
1.19
4.34
3.5
3.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
691
5899
1.19
4.31
2.4
2.6
ml/min/173m2
71.1
65.9
2.79
267
2274
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
269
2076
1.31
4.24
1.6
1.6
iu/ml
0.1
14.6
1.11
63
457
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
340
2704
1.27
4.24
3.4
3.9
mmol/l
24.6
24.8
0.38
316
2477
(3039162) Centromere protein B Ab [Units/volume] in Serum
110
729
1.52
4.21
1.2
1.3
u/ml
35.6
58.1
—
9
52
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
8
10
8.01
4.06
1.0
1.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
110
738
1.50
4.00
1.4
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
169
1229
1.38
3.98
1.6
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
59
340
1.74
3.98
1.0
1.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
139
979
1.43
3.94
1.1
1.1
g/l
1.5
1.5
0.59
123
889
(3030981) Hyaline casts [#/volume] in Urine by Automated count
469
3898
1.21
3.93
2.8
2.8
e6/l
0.2
0.3
0.58
458
3819
(3010144) Erythrocytes [#/volume] in Synovial fluid
96
628
1.53
3.93
1.4
1.4
e6/l
132582.7
113262.6
0.07
51
449
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
64
379
1.69
3.92
1.3
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
13
38
3.42
3.89
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
151
1082
1.40
3.89
1.4
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
692
5967
1.17
3.85
2.5
2.6
g/l
66.7
66.5
0.41
634
5447
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
321
2568
1.26
3.84
1.8
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
64
382
1.68
3.82
1.3
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
349
2825
1.25
3.78
2.0
1.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
634
5438
1.18
3.77
4.3
4.2
%
0.0
0.3
1.42
164
1431
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1292
11663
1.13
3.73
3.2
3.5
mmol/l
0.8
0.8
2.50
1195
10964
(3001964) Herpes simplex virus Ag [Presence] in Specimen
38
195
1.95
3.71
1.9
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
527
4458
1.19
3.68
3.2
3.7
ph
7.4
7.4
0.09
57
606
(3004588) Protein electrophoresis panel - Serum or Plasma
573
4885
1.19
3.67
2.5
2.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
639
5498
1.18
3.66
4.0
4.0
%
0.6
0.7
0.79
158
1315
(21494567) Legionella sp IgM Ab [Presence] in Serum
13
40
3.25
3.62
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
229
1771
1.30
3.61
1.2
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
81
521
1.56
3.61
4.6
4.8
u/ml
37.0
63.4
0.61
29
160
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
319
2571
1.25
3.61
2.9
2.4
g/l
3.0
3.1
1.51
252
2033
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
62
374
1.66
3.58
1.4
1.4
u/l
5.4
6.5
1.02
52
320
(3012516) Albumin [Mass/volume] in Urine
2346
21900
1.10
3.58
3.3
3.3
mg/l
525.3
362.6
0.80
1507
14289
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
184
1385
1.34
3.53
1.6
1.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
736
6426
1.16
3.51
7.0
7.3
mmol/l
1.2
1.4
4.78
708
6190
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
78
501
1.56
3.51
2.1
2.7
e6/l
585.4
645.0
0.39
30
188
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
531
4517
1.19
3.50
3.2
3.6
kpa
5.1
5.1
0.55
492
4164
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
132
944
1.40
3.48
1.4
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
237
1853
1.29
3.46
1.6
1.7
mu/l
297.7
298.5
0.01
225
1691
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
507
4301
1.19
3.45
3.2
3.6
mmol/l
1.4
1.8
1.69
373
3140
(40757373) Influenza virus identified in Isolate
28
132
2.12
3.44
2.0
1.5
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
76
488
1.56
3.43
1.2
1.2
—
44.6
—
0
27
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
69
434
1.59
3.40
2.7
2.8
%
33.7
37.2
0.71
32
141
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
318
2581
1.24
3.40
2.8
2.3
g/l
10.3
10.4
0.19
268
2189
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
32
160
2.00
3.38
1.3
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
107
742
1.45
3.36
1.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
23
101
2.28
3.35
1.0
1.1
u/ml
59.6
66.1
0.13
23
95
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
162
1207
1.35
3.35
1.7
1.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
337
2759
1.23
3.33
2.8
2.3
g/l
7.2
7.3
0.62
258
2060
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
80
524
1.53
3.32
2.2
1.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1974
18342
1.10
3.30
4.2
3.9
estimate
0.0
0.0
0.07
607
6020
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
30
148
2.03
3.29
1.1
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
39
211
1.85
3.29
1.2
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
336
2754
1.23
3.29
2.8
2.3
g/l
4.2
3.9
0.92
245
1989
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1248
11327
1.12
3.28
1.9
2.1
s
29.6
30.0
1.62
1212
11011
(3019060) Gas panel - Arterial blood
575
4954
1.17
3.27
4.1
5.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
336
2756
1.23
3.27
2.8
2.3
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
89
599
1.49
3.26
1.7
2.3
%
34.0
42.2
1.06
12
67
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
20
84
2.38
3.22
2.7
1.7
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
261
2090
1.26
3.17
2.7
2.3
g/l
0.1
0.0
0.77
241
1900
(3002173) Hemoglobin [Mass/volume] in Arterial blood
803
7114
1.14
3.14
7.8
8.5
g/l
124.8
121.8
4.07
770
6845
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
284
2299
1.24
3.14
1.5
1.7
mg/l
4.3
3.8
0.35
230
1608
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
186
1433
1.30
3.08
2.0
1.8
iu/l
4.7
4.3
0.20
63
493
(3023323) Follitropin [Units/volume] in Serum or Plasma
288
2341
1.24
3.07
1.3
1.3
iu/l
27.4
30.9
1.00
246
2028
(3005011) Chlamydia sp Ab [Titer] in Serum
20
86
2.33
3.07
1.8
1.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
287
2334
1.24
3.05
5.2
6.9
mmol/l
1.2
1.3
0.85
255
2052
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
948
8506
1.13
3.04
3.9
4.5
u/l
226.2
242.8
5.61
889
8081
(3008152) Bicarbonate [Moles/volume] in Arterial blood
542
4679
1.17
3.03
5.8
7.6
mmol/l
24.5
24.5
0.04
504
4348
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
264
2133
1.25
2.98
1.8
1.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
228
1813
1.26
2.96
1.7
1.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
118
855
1.39
2.95
1.6
1.5
%
58.8
60.1
0.12
85
528
(3016502) Oxygen saturation in Arterial blood
864
7732
1.13
2.90
7.4
8.0
%
95.7
95.6
0.13
828
7441
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
44
259
1.70
2.85
1.3
1.5
mmol/l
8.8
8.0
0.96
27
143
(3045424) Erythrocytes [Presence] in Urine
148
1118
1.33
2.85
1.4
1.5
—
—
—
0
0
(4281824)
41
686
0.60
2.84
1.1
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
483
4156
1.17
2.83
9.1
10.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
285
2343
1.22
2.77
2.8
2.4
g/l
1.3
1.0
0.38
254
2012
(3020682) Albumin/Creatinine [Ratio] in Urine
2444
23077
1.08
2.76
4.0
4.1
mg/mmol
9.9
9.6
0.07
1558
15105
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
119
875
1.36
2.74
1.6
1.7
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
15
339
0.44
2.70
1.9
6.4
mg/l
59.5
742.4
—
8
246
(3007919) Fasciola sp Ab [Titer] in Serum
6
10
6.00
2.69
1.0
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
520
5963
0.86
2.69
4.3
3.7
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
104
751
1.39
2.68
1.5
1.3
u/l
23.1
28.1
0.89
87
630
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
8
19
4.21
2.67
1.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
9
24
3.75
2.67
1.0
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
241
1956
1.24
2.66
2.8
2.4
g/l
0.0
0.0
0.39
222
1771
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
17
73
2.33
2.64
3.6
3.5
mg/l
1.1
1.1
0.04
12
47
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
71
479
1.49
2.64
1.6
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
237
1923
1.24
2.62
2.8
2.4
g/l
0.0
0.0
0.00
220
1764
(3027273) Bicarbonate [Moles/volume] in Venous blood
415
3553
1.18
2.62
3.4
3.6
mmol/l
25.4
25.1
1.44
403
3437
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
92
654
1.41
2.61
1.2
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
14
55
2.55
2.61
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
111
815
1.37
2.60
1.1
1.1
u/ml
1.9
3.8
2.35
40
378
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
319
2673
1.20
2.57
1.9
1.9
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
6
11
5.46
2.54
1.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
58
379
1.53
2.52
2.0
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
353
2993
1.19
2.51
1.7
1.8
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
64
428
1.50
2.50
1.1
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
64
428
1.50
2.50
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
64
428
1.50
2.50
1.1
1.2
—
—
—
0
0
(3012544) pH of Venous blood
780
7005
1.12
2.50
3.7
4.1
ph
7.4
7.4
—
7
39
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
41
248
1.66
2.45
1.1
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
199
1598
1.25
2.44
1.4
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
747
6702
1.13
2.44
3.6
4.1
mmol/l
1.9
1.8
0.47
613
5405
(3038177) Helicobacter pylori Ab [Presence] in Serum
136
1041
1.31
2.44
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
505
4420
1.15
2.41
2.8
2.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
84
597
1.41
2.41
1.1
1.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
552
4862
1.14
2.41
3.6
4.3
ng/l
89.7
97.6
1.33
481
4233
(3034274) Bile acid [Moles/volume] in Serum --fasting
75
523
1.44
2.39
2.0
1.9
umol/l
9.5
8.2
0.21
50
370
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
15
64
2.35
2.38
1.4
1.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
63
425
1.49
2.38
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
63
425
1.49
2.38
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
63
426
1.48
2.35
1.1
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
688
6158
1.13
2.35
2.4
2.6
e9/l
68.7
69.7
0.34
499
4705
(3017704) Immunofixation for Urine
58
386
1.51
2.34
1.3
1.5
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
68
469
1.45
2.31
1.1
1.1
—
47.2
—
0
6
(40763480) Human metapneumovirus Ag [Presence] in Specimen
9
28
3.22
2.30
1.1
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
82
586
1.40
2.30
1.5
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
82
586
1.40
2.30
1.5
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
82
586
1.40
2.30
1.5
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
99
731
1.36
2.28
2.8
3.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
258
2147
1.21
2.28
2.7
2.3
g/l
37.5
37.6
0.18
231
1856
(3021447) Carbon dioxide [Partial pressure] in Venous blood
745
6713
1.12
2.28
3.6
4.0
kpa
5.8
5.8
0.39
723
6513
(3007930) Methemoglobin/Hemoglobin.total in Blood
357
3059
1.17
2.27
4.5
5.8
%
0.9
0.9
0.34
333
2865
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
180
1447
1.25
2.22
1.4
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
25
135
1.85
2.21
1.3
1.3
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
10
36
2.78
2.20
1.2
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
86
626
1.38
2.18
1.4
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
89
653
1.37
2.16
1.1
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
38
234
1.63
2.16
1.1
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
278
2344
1.19
2.15
1.7
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
826
7514
1.11
2.14
1.5
1.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
133
1694
0.78
2.13
3.0
2.8
umol/l
32.4
35.4
0.74
111
1434
(3033799) Differential panel - Peritoneal fluid
12
266
0.45
2.12
2.0
2.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
53
355
1.50
2.11
1.4
1.8
u/field
1.6
2.8
1.23
42
256
(3009466) Valproate [Moles/volume] in Serum or Plasma
81
1102
0.73
2.09
4.2
4.9
umol/l
351.9
362.4
0.27
66
949
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
146
1155
1.27
2.09
3.2
2.6
u/ml
1955.2
1645.8
—
9
60
(3024932) HLA-DR beta [Type]
13
277
0.47
2.07
1.1
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
173
1399
1.24
2.05
3.7
3.8
%
57.7
57.9
0.07
173
1399
(3044007) Cell count panel - Peritoneal fluid
11
247
0.44
2.02
1.6
2.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
28
164
1.71
1.94
1.2
1.2
—
555.0
—
0
8
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
358
3113
1.16
1.93
4.6
5.7
%
1.7
1.7
0.03
334
2913
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
6
16
3.75
1.93
1.3
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
14
281
0.50
1.90
1.0
1.0
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
120
939
1.28
1.90
1.5
1.4
mu/l
53.2
65.5
0.31
102
839
(3017354) Segmented neutrophils/100 leukocytes in Blood
97
738
1.32
1.89
3.2
3.3
%
59.1
59.8
0.10
67
483
(3001019) Free T4 and TSH panel - Serum or Plasma
359
3129
1.15
1.89
1.7
1.7
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
181
1489
1.22
1.86
1.3
1.4
e6/l
246.7
3738.9
0.81
154
1209
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
529
4736
1.12
1.86
8.9
9.2
%
1.4
1.4
0.15
523
4705
(3039000) Anion gap in Blood
205
1708
1.21
1.85
5.8
8.0
mmol/l
11.2
11.3
0.16
183
1533
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
181
1490
1.22
1.85
1.2
1.4
e6/l
26.2
27.3
0.02
145
1141
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
200
1663
1.21
1.85
1.3
1.3
mg/l
552.0
531.9
0.18
188
1585
(3018572) Chloride [Moles/volume] in Blood
205
1709
1.20
1.84
5.8
8.0
mmol/l
105.4
105.3
0.11
183
1534
(3020891) Body temperature
338
2943
1.15
1.81
4.1
5.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
164
1340
1.23
1.81
1.3
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
104
806
1.29
1.79
1.5
1.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
70
512
1.37
1.78
1.7
1.7
mmol/l
6.6
6.8
0.51
52
352
(3049717) Cytology report of Urine Cyto stain
347
3034
1.15
1.77
2.8
2.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
261
2234
1.17
1.76
3.5
4.4
mmol/l
3.9
3.9
0.85
244
2096
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
25
147
1.70
1.73
1.0
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
450
4014
1.13
1.70
9.5
9.5
mmol/l
24.5
24.2
1.89
416
3737
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
98
760
1.29
1.70
1.1
1.1
iu/ml
1.2
2.7
—
5
18
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
103
805
1.28
1.69
1.5
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
147
1198
1.23
1.68
1.1
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
183
1526
1.20
1.67
6.0
5.5
iu/ml
353.6
1905.8
0.96
24
234
(3005988) Vibrio sp identified in Specimen by Organism specific culture
103
806
1.28
1.67
1.5
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
45
308
1.46
1.67
1.1
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
25
149
1.68
1.66
1.1
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1933
18407
1.06
1.66
3.3
3.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
53
375
1.42
1.66
1.1
1.1
nmol/l
2.9
11.4
1.14
11
82
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1009
9388
1.08
1.65
5.2
6.4
mmol/l
1.0
1.0
0.73
942
8773
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
105
825
1.28
1.65
1.5
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
50
351
1.43
1.64
6.9
6.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
61
444
1.38
1.63
2.6
4.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
598
5437
1.11
1.62
3.1
3.2
kpa
4.6
4.6
0.36
578
5257
(3025468) Yersinia sp identified in Specimen by Organism specific culture
102
801
1.28
1.62
1.5
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
31
197
1.58
1.62
2.8
3.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
52
369
1.41
1.61
1.2
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
103
811
1.27
1.60
1.5
1.4
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
7
26
2.69
1.58
1.1
1.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
102
806
1.27
1.55
1.8
1.5
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
12
234
0.51
1.55
1.1
1.3
ug/l
8.8
392.9
—
7
123
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
111
887
1.25
1.54
1.2
1.2
mmol/l
7.6
7.4
0.23
73
653
(3045716) Anion gap in Serum or Plasma
46
322
1.43
1.54
1.7
2.4
mmol/l
9.0
8.9
0.08
31
238
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
15
272
0.55
1.53
1.5
2.2
e6/l
37221.3
6847.4
—
10
154
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
115
924
1.25
1.53
1.3
1.3
nmol/l
0.6
3.7
1.09
109
886
(3037756) Immunofixation for Serum or Plasma
183
1542
1.19
1.52
1.5
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
262
2274
1.16
1.52
3.3
3.3
ratio
2.1
4.3
0.87
23
176
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
115
925
1.25
1.52
1.3
1.3
nmol/l
0.1
0.2
—
8
62
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
21
2.86
1.50
1.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
954
8897
1.08
1.49
1.5
1.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
72
1.95
1.48
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
182
1538
1.19
1.48
1.5
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
48
342
1.41
1.47
1.7
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
48
342
1.41
1.47
1.8
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
48
342
1.41
1.47
1.8
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
48
342
1.41
1.47
1.8
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
38
259
1.47
1.47
1.9
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1899
19865
0.94
1.47
1.3
1.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
670
6164
1.09
1.45
8.4
8.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
45
318
1.42
1.45
1.2
1.1
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
29
187
1.55
1.45
1.2
1.2
%
39.8
39.8
0.00
19
122
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
268
2340
1.15
1.45
3.3
3.3
mg/l
44.5
53.9
0.46
216
1879
(3004119) Hemoglobin [Mass/volume] in Venous blood
495
4490
1.11
1.44
3.2
3.5
g/l
132.4
129.5
2.35
484
4374
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
6
22
2.73
1.43
1.0
1.3
mmol/l
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
134
1619
0.82
1.43
2.9
3.7
u/ml
322.0
1018.7
0.89
119
1498
(3036603) Volume of Urine
63
474
1.33
1.40
1.5
1.7
ml
2102.4
2033.2
—
8
115
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
10
46
2.18
1.39
1.3
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
14
74
1.89
1.38
1.1
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
80
624
1.28
1.38
1.6
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
87
686
1.27
1.38
1.1
1.1
—
21.9
—
0
8
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
66
502
1.32
1.37
1.2
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
24
150
1.60
1.37
1.8
1.9
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
25
158
1.58
1.37
1.0
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
47
2.13
1.33
1.2
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
11
54
2.04
1.32
1.0
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
68
523
1.30
1.32
1.9
1.9
u/field
1.7
1.8
0.07
36
214
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
307
2726
1.13
1.32
3.2
3.6
u/ml
4112.0
2233.1
0.33
259
2362
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
15
83
1.81
1.31
1.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
37
258
1.44
1.30
1.9
2.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
37
258
1.44
1.30
1.9
2.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
119
980
1.22
1.30
1.7
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
266
2342
1.14
1.30
3.3
3.3
mg/l
61.3
84.6
0.42
214
1880
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
9
43
2.09
1.30
1.1
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
13
69
1.89
1.28
1.1
1.0
—
—
—
0
0
(3036489) Thrombin time
295
2620
1.13
1.27
1.9
2.1
s
22.2
21.5
0.34
249
2313
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
11
55
2.00
1.27
1.2
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
49
656
0.75
1.26
1.3
1.4
promille
1.3
1.3
0.17
41
492
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
288
2556
1.13
1.26
2.0
2.4
ug/l
371.5
719.7
1.53
273
2410
(1001926) Buprenorphine [Presence] in Urine by Screen method
186
1601
1.17
1.25
1.3
2.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
23
146
1.58
1.25
1.1
1.2
%
110.0
81.7
2.04
12
76
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
107
877
1.22
1.24
1.3
1.3
pmol/l
285.5
310.7
0.23
82
663
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
44
597
0.74
1.24
1.3
1.5
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
8
36
2.22
1.24
2.5
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
95
770
1.24
1.23
4.6
3.8
—
—
—
0
0
(3000012) Reticulocyte production index
30
432
0.69
1.21
1.2
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
725
6755
1.08
1.21
2.2
2.3
g/l
0.2
0.2
2.15
688
6289
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
192
1664
1.16
1.20
1.3
1.3
miu/ml
177.2
213.9
0.71
77
683
(3035320) C reactive protein [Mass/volume] in Body fluid
60
461
1.30
1.20
2.3
2.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
25
164
1.53
1.20
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
25
164
1.53
1.20
1.2
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
101
827
1.22
1.19
1.3
1.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
17
101
1.68
1.19
1.9
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
18
287
0.63
1.18
3.1
4.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
37
264
1.40
1.18
1.2
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
172
1481
1.16
1.17
1.2
1.3
mmol/l
3.8
3.9
0.31
161
1397
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
25
165
1.52
1.17
1.2
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
21
133
1.58
1.17
1.3
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
22
141
1.56
1.16
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
189
1641
1.16
1.16
1.6
1.6
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
35
248
1.41
1.16
1.8
2.0
u/ml
1585.7
26606.9
—
7
34
(3011288) Drugs identified in Urine by Screen method
158
1353
1.17
1.16
1.7
3.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
533
4914
1.09
1.15
1.4
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
147
1252
1.18
1.15
1.6
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
97
795
1.22
1.15
2.1
2.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
79
633
1.25
1.15
1.3
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
234
2065
1.14
1.14
2.4
2.6
g/l
3.8
3.6
0.77
224
1961
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
58
447
1.30
1.14
1.1
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
64
500
1.28
1.14
1.1
1.1
mg/l
43.5
43.4
0.01
55
409
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
79
634
1.25
1.13
1.3
1.3
pmol/l
1058.5
120.5
0.45
26
199
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
40
292
1.37
1.13
1.1
1.1
%
98.0
94.9
0.27
32
225
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
156
0.51
1.12
3.3
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
144
1228
1.18
1.12
1.2
1.2
u/ml
260.8
284.9
0.41
77
789
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
67
528
1.27
1.12
1.0
1.1
mg/l
292.7
282.8
0.57
58
479
(3030313) Adrenal Ab [Titer] in Serum
8
40
2.00
1.12
1.1
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
25
167
1.50
1.12
1.1
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
23
151
1.52
1.11
1.1
1.1
%
89.4
82.8
0.51
12
78
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
9
162
0.56
1.08
8.4
5.9
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
9
163
0.55
1.08
4.2
3.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
11
59
1.87
1.07
1.0
1.9
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
153
1318
1.16
1.06
1.1
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
30
211
1.42
1.05
1.1
1.1
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
33
2.12
1.05
1.3
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
45
340
1.33
1.04
1.6
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
45
340
1.33
1.04
1.6
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
941
8905
1.06
1.03
1.7
1.8
%
1.4
1.5
1.81
820
7795
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
11
60
1.83
1.02
1.0
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
100
834
1.20
1.02
1.3
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
679
6360
1.07
1.02
1.8
1.8
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
10
53
1.89
1.01
2.6
2.7
—
—
—
0
0
(3019174) dRVVT (LA screen)
10
53
1.89
1.01
1.1
1.2
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
10
53
1.89
1.01
1.1
1.1
u/l
6.3
15.6
—
10
53
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
64
510
1.26
1.00
1.0
1.0
ng/l
299.9
317.1
0.25
42
353
(3028679) Herpes simplex virus Ab [Presence] in Serum
40
299
1.34
1.00
1.1
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
58
457
1.27
1.00
1.4
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
68
841
0.81
0.99
1.4
1.6
—
—
—
0
0
(4024509)
75
610
1.23
0.99
1.4
1.5
—
—
—
0
0
(4027681)
50
387
1.29
0.99
1.1
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
58
729
0.79
0.98
1.7
1.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
40
300
1.33
0.98
2.3
2.5
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
11
61
1.80
0.98
1.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
9
50
1.80
0.96
1.1
1.5
umol/24h
286.6
358.2
—
9
50
(3044009) aPTT.lupus sensitive (LA screen)
9
50
1.80
0.96
1.1
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
236
2632
0.89
0.96
2.7
3.1
u/ml
0.4
0.3
0.17
136
1497
(3043410) Blood group antigens tested for on Red Blood Cells
13
211
0.62
0.96
1.1
1.8
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
79
650
1.22
0.94
1.4
1.5
%
30.6
27.6
0.30
54
392
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
33
242
1.37
0.94
1.1
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
166
1456
1.14
0.94
2.0
2.2
u/l
8003.5
4259.5
0.71
59
563
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
6
27
2.22
0.93
1.5
1.6
%
2.8
1.4
—
6
27
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
12
197
0.61
0.93
3.2
2.4
—
—
—
0
0
(3016750) Collection duration of Urine
35
466
0.75
0.93
2.7
2.1
min
513.0
498.1
0.42
26
356
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
249
2241
1.11
0.93
1.7
1.7
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
6
28
2.14
0.91
1.0
1.0
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
19
126
1.51
0.91
1.5
1.5
ug/l
0.4
0.4
0.25
14
71
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
49
384
1.28
0.90
1.1
1.1
ratio
1.0
1.1
0.27
13
132
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
15
94
1.60
0.90
1.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
29
210
1.38
0.90
1.6
1.9
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
67
546
1.23
0.89
1.3
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
265
2401
1.11
0.88
3.0
3.3
g/l
0.3
0.3
0.93
122
1126
(4306422)
118
1015
1.16
0.88
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
199
1776
1.12
0.87
3.2
3.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
544
5809
0.93
0.87
3.6
4.1
mmol/l
1.2
1.2
0.64
469
5126
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
41
316
1.30
0.86
2.2
2.1
umol/l
55.7
56.7
0.06
34
264
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
711
7522
0.94
0.86
3.4
3.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
34
448
0.76
0.86
1.3
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
11
64
1.72
0.86
3.1
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
11
64
1.72
0.86
1.9
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
19
128
1.49
0.85
1.1
1.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
63
513
1.23
0.85
1.0
1.0
ng/l
711.5
726.5
0.09
40
346
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
12
72
1.67
0.85
1.1
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
139
1215
1.15
0.85
3.3
3.5
%
1.1
1.6
1.16
108
943
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
118
1019
1.16
0.85
1.2
1.2
u/ml
2.7
3.9
1.69
49
468
(3020650) Glucose [Presence] in Urine
11
179
0.61
0.84
1.2
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
66
800
0.82
0.83
1.4
1.5
—
—
—
0
0
(4198724)
18
262
0.69
0.83
1.3
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
479
4472
1.08
0.83
1.4
1.6
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
26
354
0.73
0.82
1.0
1.1
u/l
27.1
31.5
0.13
20
266
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
11
65
1.69
0.82
1.0
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
63
516
1.22
0.82
1.0
1.0
ng/l
41.3
41.5
0.02
41
348
(3027008) Opiates [Presence] in Urine
233
2109
1.11
0.81
1.3
2.1
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
13
81
1.61
0.81
1.5
1.3
—
98.6
—
0
5
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
366
3388
1.08
0.79
3.7
4.4
mmol/l
24.1
24.0
0.10
326
3029
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
71
591
1.20
0.79
1.7
1.7
mg/l
3.6
4.1
0.52
71
558
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
58
473
1.23
0.79
1.4
1.3
g/l
1.6
1.5
—
5
25
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
11
66
1.67
0.78
1.1
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
60
492
1.22
0.78
1.4
1.8
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
14
90
1.56
0.78
1.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
73
611
1.20
0.77
1.5
1.7
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
28
208
1.35
0.77
1.2
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
233
2117
1.10
0.77
1.3
2.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
70
835
0.84
0.77
1.5
1.5
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
59
484
1.22
0.77
1.0
1.1
mg/l
257.2
283.7
0.54
52
418
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
34
1.77
0.76
1.3
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
135
1190
1.14
0.75
1.5
1.3
u/l
32.1
33.1
0.03
119
1021
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
84
715
1.18
0.75
3.0
3.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
9
54
1.67
0.74
1.6
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
20
141
1.42
0.74
2.1
5.7
u/l
98.2
86.3
—
6
51
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
45
360
1.25
0.74
1.9
2.8
u/l
199.6
199.8
0.00
45
355
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
49
396
1.24
0.74
1.4
1.5
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
16
108
1.48
0.73
1.1
1.4
%
108.6
102.2
0.37
16
100
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
49
397
1.24
0.72
1.4
1.5
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
14
92
1.52
0.72
1.2
1.6
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
357
3319
1.08
0.72
2.7
2.9
%
0.6
0.7
0.30
346
3170
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
11
171
0.64
0.71
6.5
7.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
94
1086
0.86
0.71
1.4
1.5
g/l
33.2
33.0
0.06
87
977
(3027944) Amphetamines [Presence] in Urine
227
2071
1.10
0.71
1.3
2.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
727
6924
1.05
0.70
1.4
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
7
41
1.71
0.70
1.0
1.0
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
17
118
1.44
0.69
1.1
1.2
ng/l
214.3
820.1
—
10
85
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
215
1960
1.10
0.69
2.4
2.5
%
183.3
198.8
1.84
203
1877
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
9
59
1.53
0.68
6.7
2.6
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
22
161
1.37
0.68
2.0
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
229
2097
1.09
0.67
1.3
2.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
214
1954
1.10
0.67
1.3
2.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
178
1964
0.90
0.66
2.3
2.4
ug/min
111.3
131.9
0.31
99
1212
(3003181) Sodium [Moles/volume] in Urine
128
1137
1.13
0.66
1.3
1.3
mmol/l
68.4
63.4
0.66
101
896
(3034426) Prothrombin time (PT)
18
249
0.72
0.66
1.2
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
143
1279
1.12
0.66
1.3
1.5
u/ml
130.5
111.3
0.33
31
272
(3036670) Protein [Mass/volume] in Synovial fluid
26
197
1.32
0.65
1.2
1.2
g/l
45.6
39.9
1.07
11
102
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
33
259
1.28
0.65
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
157
1414
1.11
0.65
1.3
1.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
24
180
1.33
0.64
1.2
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1528
14843
1.04
0.62
1.7
1.7
pmol/l
74941881.7
34068571.1
1.10
1281
12384
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
11
71
1.55
0.62
1.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
15
211
0.71
0.62
7.3
7.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
168
1524
1.10
0.61
1.9
2.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
117
1041
1.13
0.61
1.2
1.2
u/ml
3.6
3.6
0.01
32
353
(3006969) Lambda light chains [Mass/volume] in Urine
0
20
0.00
0.60
0.0
1.0
—
0.0
—
0
8
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
26
200
1.30
0.60
1.5
1.5
ug/l
8.5
9.2
0.47
26
200
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
17
122
1.39
0.60
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
43
353
1.22
0.59
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
41
335
1.22
0.59
1.2
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
434
4100
1.06
0.59
1.4
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
101
894
1.13
0.58
1.4
1.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
57
670
0.85
0.58
2.4
2.2
ml
746.8
658.8
0.58
33
464
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
6
35
1.71
0.57
1.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
18
242
0.74
0.57
7.3
7.6
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
51
428
1.19
0.57
1.2
1.2
u/l
102.2
92.1
0.31
39
363
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
29
229
1.27
0.56
1.1
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
88
0.57
0.56
2.4
1.1
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
6
37
1.62
0.55
1.0
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
9
60
1.50
0.54
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
96
852
1.13
0.54
1.1
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
208
1922
1.08
0.54
2.7
3.2
mmol/l
24.4
24.8
0.95
180
1682
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
49
413
1.19
0.54
1.2
1.2
u/l
20.2
20.4
0.02
37
346
(44816559) Phosphatidylethanol [Mass/volume] in Blood
149
1357
1.10
0.53
1.3
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
65
562
1.16
0.53
1.2
1.3
mmol/l
10.9
12.4
0.76
19
164
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
9
62
1.45
0.53
1.1
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
37
447
0.83
0.52
1.6
1.5
u/l
7.9
5.6
0.32
21
207
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
41
341
1.20
0.52
1.1
1.1
u/l
1.1
1.1
0.02
21
154
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
20
152
1.32
0.52
1.4
1.2
pmol/l
470.4
282.5
0.72
12
117
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
6
40
1.50
0.51
5.2
1.7
mg/l
1.6
2.3
—
6
32
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
17
126
1.35
0.51
1.2
1.6
ug/l
3.6
2.0
—
8
73
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
19
248
0.77
0.51
1.6
2.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
94
837
1.12
0.51
1.1
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
42
351
1.20
0.51
4.2
11.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
135
1227
1.10
0.51
1.7
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
95
847
1.12
0.50
1.4
1.6
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
11
75
1.47
0.50
1.0
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
110
990
1.11
0.50
1.1
1.1
%
118.0
115.9
0.31
95
894
(3006184) Hemoglobin [Mass/volume] in Capillary blood
178
1642
1.09
0.49
2.2
2.2
g/l
131.3
129.2
0.48
123
1211
(3033923) Metanephrine [Moles/time] in 24 hour Urine
17
127
1.34
0.49
1.1
1.1
umol/24h
0.7
1.2
—
8
63
(4034850)
246
2299
1.07
0.49
8.0
9.9
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
26
207
1.26
0.49
1.6
1.9
mg/l
9.1
9.1
0.02
18
165
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
12
167
0.72
0.49
1.2
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
7
45
1.56
0.48
1.6
3.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
209
1943
1.08
0.48
1.1
1.2
titre
1095.0
899.7
—
8
58
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
25
312
0.80
0.48
1.2
1.4
%
60.7
63.9
0.16
20
258
(3023199) Leukocytes [#/volume] in Pleural fluid
85
954
0.89
0.48
1.5
1.5
e6/l
3672.9
2223.1
0.69
62
693
(40761539) Cells [Type] in Urine sediment by Light microscopy
23
181
1.27
0.47
1.1
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
66
751
0.88
0.47
1.5
1.5
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
32
263
1.22
0.47
1.1
1.1
ng/l
820.8
350.8
—
6
70
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
106
1171
0.90
0.46
1.1
1.1
iu/ml
18.9
9099.5
0.53
21
256
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
319
3016
1.06
0.46
1.9
2.0
ug/l
1.9
2.4
0.29
272
2683
(40762365) Oxygen content in Arterial blood by calculation
10
142
0.70
0.46
2.2
2.9
ml/dl
14.5
14.7
—
10
133
(3051101) Glucose [Moles/volume] in Cord blood
10
142
0.70
0.46
8.1
6.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
39
328
1.19
0.46
1.4
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
53
459
1.16
0.45
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
76
676
1.13
0.44
1.3
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
53
460
1.15
0.44
1.0
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
89
800
1.11
0.43
1.6
2.0
titre
608.0
1586.4
—
5
47
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
12
163
0.74
0.43
1.3
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
185
1985
0.93
0.43
2.8
3.0
mg/l
1.5
1.6
0.32
169
1819
(3028626) Oxygen [Partial pressure] in Capillary blood
173
1607
1.08
0.43
2.8
2.9
kpa
8.2
8.0
0.52
156
1487
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
28
230
1.22
0.42
1.1
1.2
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
32
1.56
0.42
1.0
1.9
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
701
6777
1.04
0.41
6.0
8.1
mmol/l
9.5
10.2
1.84
658
6471
(3006922) Hepatitis E virus Ab [Presence] in Serum
56
491
1.14
0.41
1.1
1.1
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
16
0.00
0.41
0.0
1.1
—
1879.5
—
0
16
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
64
721
0.89
0.41
1.3
1.4
nmol/l
0.4
0.3
0.12
44
542
(1761482) Bacteria [#/volume] in Urine by Culture
179
1918
0.93
0.41
4.6
3.8
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
145
1566
0.92
0.40
1.8
2.0
nmol/l
0.9
0.8
0.55
131
1311
(3050129) First trimester maternal screen panel - Serum or Plasma
113
1034
1.09
0.40
1.5
1.4
—
—
—
0
0
(4211845)
39
333
1.17
0.40
2.5
3.1
—
—
—
0
0
(3043722) Hyaline casts [#/area] in Urine sediment by Automated count
0
18
0.00
0.40
0.0
1.0
—
1.3
—
0
18
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
19
238
0.80
0.40
1.3
1.2
umol/l
3.6
4.1
0.28
19
225
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
37
315
1.18
0.39
1.8
3.0
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
45
390
1.15
0.39
1.3
1.3
nmol/l
1.0
1.2
0.85
31
303
(3004451) EKG impression Narrative
42
362
1.16
0.39
1.3
1.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
19
0.00
0.39
0.0
6.0
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
19
0.00
0.39
0.0
4.2
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
14
106
1.32
0.39
1.2
1.3
%
48.3
56.5
—
7
44
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
14
106
1.32
0.39
1.4
1.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
65
579
1.12
0.38
1.0
1.2
nmol/l
321.1
349.1
0.60
49
484
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
42
363
1.16
0.38
1.4
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
127
1173
1.08
0.38
1.0
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
43
373
1.15
0.37
1.7
2.3
ml
1834.4
1973.8
0.38
34
327
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
24
197
1.22
0.37
1.7
2.4
%
164.8
191.9
0.77
24
184
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
17
134
1.27
0.36
1.2
1.2
mg/l
0.7
71.1
0.80
12
101
(3007566) Smooth muscle Ab [Titer] in Serum
209
1970
1.06
0.36
1.2
1.3
titre
86.5
158.7
1.16
20
177
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
210
1980
1.06
0.36
1.3
1.3
—
—
—
0
0
(4035726)
651
6306
1.03
0.36
1.4
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
78
0.64
0.35
1.2
1.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
45
394
1.14
0.35
2.0
2.2
ug/min
70.4
135.4
—
5
104
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
52
460
1.13
0.35
1.3
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
17
212
0.80
0.35
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
91
832
1.09
0.35
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
91
832
1.09
0.35
1.4
1.4
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
9
122
0.74
0.35
1.8
1.5
—
102.8
—
0
21
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
15
117
1.28
0.35
1.3
1.3
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
44
1.36
0.34
1.3
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
53
471
1.13
0.34
1.3
1.4
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
6
45
1.33
0.33
1.0
1.1
—
5.1
—
0
10
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
16
127
1.26
0.33
1.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
74
672
1.10
0.33
1.3
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
349
3349
1.04
0.33
1.6
1.7
g/l
1.6
1.5
0.48
294
2883
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
42
369
1.14
0.32
1.0
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
87
798
1.09
0.32
1.2
1.2
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
6
47
1.28
0.32
1.2
1.9
umol/l
1.5
1.4
—
6
41
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
10
74
1.35
0.32
1.9
2.6
u/field
0.4
0.5
—
10
74
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
15
119
1.26
0.31
2.2
2.1
umol/l
12.7
16.7
1.40
15
119
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
13
101
1.29
0.31
1.1
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
42
370
1.14
0.31
2.0
1.8
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
90
829
1.09
0.31
1.4
1.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
99
1069
0.93
0.31
6.1
6.7
mg/l
10.9
11.4
0.85
89
985
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
21
251
0.84
0.30
1.7
1.8
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
27
230
1.17
0.30
1.1
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
7
100
0.70
0.30
2.6
2.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
147
1382
1.06
0.30
1.2
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
16
129
1.24
0.30
2.6
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
90
831
1.08
0.30
1.4
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
50
557
0.90
0.29
1.4
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
94
871
1.08
0.29
1.5
2.9
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
7
57
1.23
0.29
3.3
2.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
35
307
1.14
0.28
2.5
3.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
32
279
1.15
0.28
1.3
1.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
29
251
1.16
0.28
1.1
1.2
g/l
—
0.2
—
0
16
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
11
140
0.79
0.28
1.3
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
11
85
1.29
0.28
1.3
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
80
866
0.92
0.27
1.5
1.5
e6/l
78983.6
50001.1
0.38
45
527
(40765089) Chromosome analysis panel - Blood by G-banded
18
149
1.21
0.27
1.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
146
1379
1.06
0.27
2.7
2.9
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
16
131
1.22
0.27
1.3
1.6
ng/l
103.7
142.4
0.75
16
131
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
8
65
1.23
0.27
1.0
1.1
umol/24h
1.9
1.9
—
8
65
(3036782) Glucose [Moles/volume] in Pleural fluid
70
761
0.92
0.27
1.3
1.4
mmol/l
6.0
6.4
0.45
65
704
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
66
1.21
0.26
1.3
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
16
193
0.83
0.26
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
77
712
1.08
0.26
1.2
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
17
141
1.21
0.26
1.0
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
13
160
0.81
0.26
1.1
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
17
203
0.84
0.25
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
65
597
1.09
0.25
1.3
1.3
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
39
349
1.12
0.25
32.8
24.4
ug/l
105.4
114.1
0.46
32
281
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
63
579
1.09
0.25
1.0
1.1
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
9
76
1.18
0.24
1.8
1.7
mg/l
1.4
1.6
—
9
66
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
10
126
0.79
0.24
3.1
3.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
29
328
0.88
0.23
3.8
2.9
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
38
1.32
0.23
1.0
9.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
39
351
1.11
0.23
1.4
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
39
351
1.11
0.23
1.4
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
751
7663
0.98
0.23
3.8
4.3
ug/l
42.4
25.0
0.40
610
6335
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
92
0.76
0.22
1.1
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
5
40
1.25
0.22
1.6
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
157
0.83
0.22
1.1
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
792
7769
1.02
0.22
1.4
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
39
352
1.11
0.22
4.0
3.7
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
25
219
1.14
0.22
1.7
1.5
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
42
1.19
0.21
1.2
1.0
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
118.5
—
0
10
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.0
—
127.1
—
0
10
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
40
363
1.10
0.21
1.2
1.2
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
5
43
1.16
0.21
1.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
199
2069
0.96
0.21
1.2
1.2
—
—
—
0
0
(3010421) pH of Blood
190
1977
0.96
0.21
4.1
4.2
ph
7.4
7.4
0.61
165
1680
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
28
314
0.89
0.20
1.1
1.6
umol/l
63.5
136.2
2.41
14
147
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
67
718
0.93
0.20
1.2
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
73
683
1.07
0.20
1.3
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
126
1200
1.05
0.20
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
107
1128
0.95
0.20
1.3
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
27
240
1.13
0.20
1.8
1.7
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
9
112
0.80
0.20
1.1
1.1
—
4.7
—
0
12
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
72
674
1.07
0.20
1.4
1.3
nmol/l
1.3
1.5
0.57
60
610
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
50
1.20
0.19
1.2
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
73
684
1.07
0.19
1.4
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
175
1682
1.04
0.19
1.4
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
71
665
1.07
0.19
1.4
1.3
mosm/kgh2o
281.3
281.0
0.06
57
527
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
80
753
1.06
0.19
1.1
1.1
%
92.8
97.9
0.90
72
708
(3013727) Leukocytes other/100 leukocytes in Blood
22
249
0.88
0.19
4.2
3.7
%
50.1
55.0
0.52
22
241
(3013166) Neutrophils/100 leukocytes in Synovial fluid
24
213
1.13
0.18
1.1
1.4
%
55.1
60.1
0.25
19
183
(43055442) Apixaban [Mass/volume] in Serum or Plasma
12
100
1.20
0.18
1.3
1.5
ug/l
88.9
113.3
0.54
12
82
(3001729) Color of Synovial fluid
7
59
1.19
0.18
1.3
1.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
43
396
1.09
0.18
1.7
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
55
590
0.93
0.18
1.6
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
24
214
1.12
0.17
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
212
2052
1.03
0.17
1.3
1.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
148
1538
0.96
0.17
3.0
3.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
87
826
1.05
0.16
4.1
15.4
mmol/l
7.7
7.5
0.12
69
680
(3043238) Trisomy 21 risk [Likelihood] in Fetus
75
709
1.06
0.16
1.4
1.5
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
37
340
1.09
0.16
1.4
1.5
%
4.5
2.9
—
8
77
(3041806) Other cells [#/volume] in Blood by Manual count
14
120
1.17
0.16
1.4
1.5
—
—
—
0
0
(44806420)
18
204
0.88
0.16
2.3
2.3
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
11
92
1.20
0.16
1.5
1.1
—
—
—
0
0
(3025315) Body weight
6
77
0.78
0.15
4.8
4.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
131
1261
1.04
0.15
2.9
3.0
nmol/l
0.8
0.8
0.14
103
954
(3026250) Tacrolimus [Mass/volume] in Blood
37
342
1.08
0.15
32.6
35.9
ug/l
7.3
7.4
0.20
28
318
(3018133) Calcium [Moles/volume] in Urine
7
90
0.78
0.14
1.4
1.6
mmol/l
1.8
2.7
—
7
74
(3016018) Differential panel - Cerebral spinal fluid
72
685
1.05
0.13
1.3
1.4
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
99
950
1.04
0.13
2.1
1.9
%
89.9
89.5
0.34
99
931
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
113
1088
1.04
0.13
1.3
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
29
315
0.92
0.13
1.2
1.1
miu/ml
1213.3
1439.7
0.52
29
315
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
158
1628
0.97
0.13
1.4
1.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
10
85
1.18
0.12
1.8
1.9
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
64
610
1.05
0.12
1.3
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
21
191
1.10
0.11
1.3
1.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
105
1014
1.04
0.11
1.1
1.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
28
302
0.93
0.11
1.6
2.0
%
6.3
8.5
0.62
28
291
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
25
271
0.92
0.11
1.1
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
11
126
0.87
0.11
8.5
11.0
mmol/l
6.1
5.5
0.29
11
126
(3025577) Chromium [Mass/volume] in Blood
48
455
1.06
0.11
2.0
2.0
ug/l
1.8
2.5
1.46
37
386
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
10
86
1.16
0.11
1.3
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
16
144
1.11
0.10
1.8
2.8
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
31
290
1.07
0.10
3.0
2.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
2613
26011
1.01
0.10
2.8
2.9
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
6.8
5.8
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
120
1233
0.97
0.09
3.0
3.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
30
282
1.06
0.08
1.1
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
225
2211
1.02
0.08
2.1
2.2
%
92.9
89.9
1.28
207
2071
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
62
0.81
0.08
2.2
2.1
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
5
65
0.77
0.08
2.2
2.0
mg/l
25.2
20.2
—
5
59
(1616796) Gas panel - Central venous blood
176
1726
1.02
0.08
3.9
3.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
7
64
1.09
0.08
1.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
25
234
1.07
0.08
1.5
2.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
25
234
1.07
0.08
1.5
2.8
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
7
65
1.08
0.08
1.1
1.2
mmol/l
217.4
177.4
—
7
58
(3000330) Specific gravity of Urine by Test strip
353
3575
0.99
0.08
3.6
3.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
34
358
0.95
0.07
2.3
2.0
—
—
—
0
0
(4212803)
6
72
0.83
0.07
1.2
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
72
743
0.97
0.07
1.2
1.2
u/l
58.3
64.0
0.44
47
494
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
8
75
1.07
0.07
2.0
2.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
8
78
1.03
0.07
2.0
2.1
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
7
83
0.84
0.07
1.0
1.2
mmol/l
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
7
85
0.82
0.07
1.0
1.2
mmol/l
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
9
87
1.03
0.07
6.9
10.9
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
155
1522
1.02
0.07
3.8
3.3
mg/l
26.0
30.1
0.64
91
991
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
10
89
1.12
0.06
1.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
15
138
1.09
0.06
1.3
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
55
568
0.97
0.06
2.6
2.1
%
12.2
11.0
1.06
55
568
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
450
4472
1.01
0.04
7.8
7.4
mmol/l
25.0
24.6
1.15
445
4433
(21494814) CD8 cells/100 lymphocytes in Specimen
28
291
0.96
0.04
1.5
2.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
11
119
0.92
0.03
2.2
2.3
ug/l
4.6
3.8
—
5
35
(3033705) Calcium.ionized [Moles/volume] in Venous blood
88
895
0.98
0.03
2.7
2.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
43
419
1.03
0.03
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
46
449
1.02
0.03
1.3
1.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
30
310
0.97
0.03
1.4
1.7
—
—
—
0
0
(4268621)
72
708
1.02
0.03
2.3
2.3
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
38
390
0.97
0.02
6.1
6.2
u/ml
48.2
8882.7
—
6
79
(3019977) pH of Arterial blood
43
440
0.98
0.02
1.9
2.5
ph
7.4
7.4
0.51
12
153
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
73
741
0.99
0.02
2.4
2.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
44
431
1.02
0.02
1.1
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
11
117
0.94
0.01
1.5
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
17
163
1.04
0.01
1.1
1.5
—
—
—
0
0
(4133840)
22
227
0.97
0.01
1.3
1.2
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
28
287
0.98
0.01
1.8
1.7
nmol/l
5.3
13.6
0.49
19
247
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
43
437
0.98
0.01
1.3
1.8
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
171
1718
1.00
0.01
4.3
4.3
kpa
5.0
5.0
0.14
165
1678
(3000034) Microalbumin [Mass/volume] in Urine
71
717
0.99
0.01
2.7
3.0
mg/l
66.3
54.0
0.15
52
524
(3012501) Base excess in Blood by calculation
171
1717
1.00
0.00
4.3
4.3
mmol/l
2.5
2.5
0.03
119
1133
(3027315) Oxygen [Partial pressure] in Blood
172
1726
1.00
0.00
4.3
4.3
kpa
8.6
8.6
0.04
166
1685
(3052592) Norovirus Ag [Presence] in Stool
14
143
0.98
0.00
1.4
1.4
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
17
167
1.02
0.00
1.5
2.3
mmol/l
9.5
7.6
0.44
11
92
(3014891) Appearance of Pleural fluid
10
104
0.96
0.00
1.6
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
124
0.97
0.00
4.8
5.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
15
146
1.03
0.00
1.3
1.3
mu/l
30.3
56.8
—
10
112
(3016038) Potassium [Moles/volume] in Urine
42
417
1.01
0.00
1.2
1.1
mmol/l
37.8
35.6
0.25
35
367
(42529582) MDA5 Ab [Presence] in Serum by Line blot
17
174
0.98
0.00
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
17
174
0.98
0.00
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
17
174
0.98
0.00
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
17
174
0.98
0.00
1.1
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
22
224
0.98
0.00
1.5
1.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
91
907
1.00
0.00
2.6
2.3
mmol/l
4.1
4.1
0.55
91
893
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
71
706
1.01
0.00
1.5
1.4
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
11
115
0.96
0.00
1.5
1.2
mmol/l
0.2
1.5
—
6
75
(40767503) Oxygen content in Capillary blood by calculation
161
1606
1.00
0.00
2.8
2.5
%
16.2
16.3
0.19
83
842
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
185
1.03
0.00
1.1
1.1
—
—
—
0
0
(4146454)
81
805
1.01
0.00
2.8
2.7
—
—
—
0
0
(44806071)
10
98
1.02
0.00
1.0
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
26
262
0.99
0.00
1.1
1.1
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
0
7
0.00
0.00
0.0
1.0
—
286.0
—
0
7
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
7.6
—
—
—
0
0
(3035153) Lemon IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
42.0
—
0
8
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007147) Virus identified in Stool by Electron microscopy
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3019529) Immunofixation for Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
8
81
0.99
0.00
1.0
2.0
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
5
49
1.02
0.00
5.8
10.3
e6/l
263.4
190.7
—
5
35
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
67
0.90
0.00
1.2
1.3
—
—
—
0
0
(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
87.0
—
0
6
(3003577) Lead [Moles/volume] in Blood
5
54
0.93
0.00
1.0
1.4
—
0.2
—
0
18
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
8
82
0.98
0.00
1.6
1.4
%
56.4
70.2
—
8
68
(3026726) Creatinine [Moles/volume] in Specimen
8
80
1.00
0.00
2.0
2.5
umol/l
558.8
288.7
—
8
75
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
75
0.93
0.00
1.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint J10_NASALPOLYP and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_NASALPOLYP | 0.915 [0.83, 1.01] | 0.074 |
| Birth year | 0.996 [0.99, 1.0] | 0.359 |
During the follow-up period (1.1.1998 — 31.12.2019), 1298 out of 14093 females with J10_NASALPOLYP died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| J10_NASALPOLYP | 0.848 [0.78, 0.92] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 3609 out of 26939 males with J10_NASALPOLYP died.
Mortality risk
Mortality risk for people of age
years, who have J10_NASALPOLYP.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.08% | 0.169% |
| 5 | 0.484% | 0.807% |
| 10 | 1.265% | 2.158% |
| 15 | 2.553% | 4.254% |
| 20 | 4.582% | 7.509% |
Relationships between endpoints
↥Index endpoint: J10_NASALPOLYP – Nasal polyp
GWS hits: 50
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data